ࡱ>  bjbj** GH|H|.| | 8,;j WV= "r%F&l$,v9ȴ>"^"ȴȴ= $```ȴ$4= `ȴ`` J,;:0j4fQ`& >3`4<,`Chq&&&l&&&jȴȴȴȴ&&&&&&&&&| : ,  CURRICULUM VITAE GUSTAVO DANIEL LOPARDO, MD  April 2016  name: Gustavo Daniel Lopardo present title: Staff member FUNCEI. Buenos Aires, Argentina. Staff member of the department of infectious Hospital Bernardo Houssay, Vicente Lpez, Buenos Aires, Argentina. address: Figueroa Alcorta 3044 10th D (1425) - Buenos Aires, Argentina. Mobile phone 15 4403 5708 E-mail: glopardo@intramed.net office address: French 3085. (1425) - Buenos Aires, Argentina citizenship: Argentine birthdate: December 12th, 1961 EDUCATION March, 1975 through Colegio Nacional de Adrogu December, 1979 "Almirante G. Brown" Buenos Aires, Argentina Grade point average: 9.04 (scale of 0-10) March, 1981 through Universidad de Buenos Aires December, 1986 Facultad de Medicina (Medical School) Degree: Medical Doctor Grade point average: 8.90 (scale of 0-10) postgraduate training May 2, 1987 through Residency in Internal Medicine April 30, 1990 Department of Internal Medicine Sanatorio Gemes-Hospital Privado. Buenos Aires, Argentina. Elective Rotations: May, 1989 through Department of Infectious Diseases and July, 1989 Preventive Medicine Sanatorio Gemes-Hospital Privado. Buenos Aires, Argentina August, 1989 through Department of Hematology October, 1989 Hospital de Clnicas "Jos de San Martn". Buenos Aires, Argentina October, 1989 through Department of Internal Medicine December, 1989 Clnica Modelo Morn. Buenos Aires, Argentina May 2, 1990 through Fellowship in Infectious Diseases. April 30, 1992, Department of Infectious Disease and Preventive Medicine. Sanatorio Gemes-Hospital Privado. Buenos Aires, Argentina Elective Rotations: September 12-20, 1992 Department of Special Immunology. Jackson Memorial Hospital. University of Miami. Miami, FLA. USA. Sept. 22, 1992 through Department of Infectious Diseases. MD Anderson Cancer October 26, 1992 Center. Houston, TX. USA March 2001-July 2001. Training in Research Methodology. Academia Nacional de Medicina. Curso de formacin de investigadores clnicos. Prof. Dr. Jos Tessler. Duracin 145 horas. GEDIC, Grupo de Estudio, Docencia e Investigacin Clnica. 2003. academic appointments October, 1983 through Teaching Assistant February, 1987 Department of Physiology Universidad de Buenos Aires, Medical School April, 1993 through Teaching Assistant May 2006 Department of Medicine, Infectious Diseases Teaching Unit of Hospital Durand Universidad de Buenos Aires, Medical School May 2006 through Assistant professor, Infectious Diseases present date Universidad de Buenos Aires, Medical School 1998 Board Certified as Infectious Diseases Specialist, by Academia Nacional de Medicina 2008 Recertified Infectious Diseases, by Academia Nacional de Medicina languages Proficiency in English Cambridge Institute of English Culture Advanced courses Buenos Aires, Argentina Proficiency in French Alianza Francesa de Buenos Aires Intermediate Courses Buenos Aires, Argentina honors and awards December, 1986 Diploma of Honor Universidad de Buenos Aires, Medical School May 2006 Best abstract about HIV infection, titled: Lopardo G, Bissio E, Crespo A, Garone D, Bugara G. No se hallaron alteraciones en el funcionamiento neurocognitivo de pacientes VIH reactivos con inmunidad conservada, ni tampoco diferencias entre pacientes con inmunidad conservada recibiendo HAART o naive de tratamiento. Abstract 190. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina May 2008 Award Espinola L, Lopardo G, Niccodemi MC, Guzzi L, Poggi E, Lijavetzky A, Barcelona L, Luna C, Rodrguez E, Corral J, Peyrani P, Ramrez J. Mortalidad en pacientes con neumona provenientes de geritrico: estudio caso-control. VIII Congreso de la Sociedad Argentina de Infectologa. Mar del Plata May 22-24 2008. Oral session. Abstract 22894 April 2009 Third pice: Lopardo G, Guzzi L, Niccodemi MC, Peyrani P, Ramirez J. Severity of desease and non-streptococcus pneumoniae bacteriemia in hospitalized patients with community-acquired pneumonia: result from the CAPO international cohort study. XIV Congreso de la Asociacin Panamericana de infectologa. Campos do Jordao. April 25-28, 2009. May 2011 Third pice: Lopardo, G; Bissio, E; Peyrani, P; Ramirez, J; Grupo CAPO. The use of macrolides was associated with lower mortality in patients with bacteremic pneumonia. XI Congreso de la Sociedad Argentina de Infectologa, Mar del Plata 19 y 20 de mayo de 2011. Abstract 29129 June 2013 Segundo Premio: Monczor A, Confalonieri V, Monserrat M, Copertari G, Fernandez Mozun F, Tempelsman R, Lopardo G. Durabilidad de los esquemas de tratamiento antiretroviral Mar del Plata 9-1 de junio de 2013. 20129. PROFESSIONAL EXPERIENCE May 1990 through Emergency Room Staff December 1996 Centro Integral Mdico (CIM). Buenos Aires, Argentina May 1992 through Outpatient Parenteral Antibiotic Therapy Program Coordinator. 2002 Centro de Estudios Infectolgicos. (CEI). Buenos Aires, Argentina May, 1992 through Staff Member. Department of Infectious Diseases July 1998 Instituto de las Clnicas Cardiovasculares. Buenos Aires, Argentina May 1992- June 1993 Sanatorio Gemes-Hospital Privado Medical Staff, Department of Infectious Diseases. Buenos Aires, Argentina May 1992 through Staff member FUNCEI, Buenos Aires, Argentina Present date June 1995 through Staff member. Department of Infectious Diseases April 2004 Clnica La Sagrada Familia, Buenos Aires, Argentina 2003 through present date Staff member of the department of Infectious diseases, Hospital Prof. Dr. Bernardo Houssay, Hospital Municipal de Vicente Lpez SCIENTIFIC AFFILIATIONS: 1992 through Panamerican Society of Infectious Diseases present date Member 1996 through Sociedad Argentina de Infectologa Currently President of the Argentinian Society of Infectious Diseases 1996 through Sociedad Argentina de Microbiologa present date Member 1998 through International AIDS Society (IAS) present date Member April 2007 through Coordinator of the Argentinean chapter of APUA (Alliance 2008 for the prudent use of antibiotics) International Society of Infectious Diseases (ISID) Member PUBLICATIONS a. abstracts: Stamboulian D, Lopardo G. Infections associated with renal transplantation. Our experience during the period from 1/90 through 12/91. 2do. Congreso de la Sociedad Argentina de Infectologa. Buenos Aires. April 26-29, 1992. Lepetic A, Rosenthal V, Altclas J, Lopardo G, Finquelievich J, Stamboulian D. Infections in renal transplant recipients in the late period. Our experience between 1/90-12/91. 2do. Congreso de la Sociedad Argentina de Infectologa. Buenos Aires, April 26-29, 1992. Argello E, Lopardo G, Marn M, Absis D, Stamboulian D. Purulent mediastinitis post cardiovascular surgery. International Congress for Infectious Diseases. Nairobi, Kenya. June 7-11, 1992. Argello E, Bermejo J, Lopardo G, Absi D, Stamboulian D. Purulent mediastinitis after cardiac surgery. Prospective study of 231 cases: 1979-92. VI Congreso Panamericano de Infectologa. X Congreso Chileno de Infectologa. Via del Mar, Chile. May 26-29, 1993. Lopardo G, Stamboulian D. Outpatient treatment of severe infectious diseases. II Simposio Internacional de Infectologa Peditrica. I Congreso Interamericano de Infectologa. Jornadas Franco Argentinas de Infectologa. Crdoba, May 8-11, 1994. Lopardo G, Carbone E, Pensotti C, Cassetti I, Stamboulian D. Establishing an outpatient parental antibiotic therapy program in Argentina. Outpatient Intravenous Infusion Therapy Association (OPIVITA) III Annual Education Conference. Chicago, IL. April 21-22, 1995. Lopardo G, Cassetti I, Vujacich C, Stamboulian D. Seroprevalence of Hepatitis B and C, toxoplasmosis and VDRL in HIV positive patients seen in an ambulatory center. VII Congreso Panamericano de Infectologa. Cartagena de Indias, Colombia. May 28-31, 1995. (Abstract C-25.247). Cassetti I, Lopardo G, Vujacich C, Batalla V, Stamboulian D. Relationship between the CD4 cell count and development of oportunistic infections in HIV positive individuals. II Congreso Argentino de SIDA, Crdoba. October 26-29, 1995. (Abstract PA8-110). Bonvehi P, Lopardo G, Falco A, Temporiti E, Relloso S, Cassetti L, Ruttimann R, Herrera F, Smayevsky J, Stamboulian D. Candidemia in adult HIV positive patients: a report of five cases without risk factor for candidemia. XI International Conference on AIDS. Vancouver, Canada. July 7-12, 1996.. (Abstract We.B.3219). Belloso W, Marchetti M, Lopardo G y col. Long term efficacy of low dose intermittent cotrimoxazole for Pneumocistis carinii prophilaxis in AIDS patients. XI Conference on AIDS. Vancouver, Canada. July 7-12, 1996.(Abstract Pub.B.1031). Lopardo G, Sturba E, Roel J y col. Incidence of infections due to Mycoplasma pneumoniae, Chlamydia spp y Legionella pneumophila in a group of patients with community adquired pneumonia. I Congreso de infectologa y microbiologia clnica (SADI-SADEBAC). Buenos Aires, July 15-18,1997. (Abstract D327) Nacinovich F, Lopardo G, Stamboulian D. Outpatient parenteral antibiotic therapy in the elderly. I Congreso de infectologa y microbiologa clnica (SADI-SADEBAC). Buenos Aires, July 15-18,1997. (Abstract K328). Lopardo G, Stamboulian D, Cassetti L. Polirradiculomielopatia asociada a Citomegalovirus en un paciente con SIDA. III Congreso Argentino de SIDA. Mar del Plata, November 27-30,1997. Belloso W., Lopardo G., Tessler J, Stern L.D., Rodrguez V., Vasen W., Etchegoyen M.. Quality of life assessment in patients with HIV infection in Argentina. 12th World AIDS Conference Geneve. June28-July 3, 1998. (Abstract 14341). Lopardo G, Belloso W, Quiros R, Bottaro E, Barcan L, Ivalo S, Lazovski J. Factors associated with hipercholesterolemia (HC) and hipertriglyceridemia (HT) in HIV positive patients. 36th Annual Meeting of the Infectious Diseases Society of America (IDSA), Denver, Co, USA. November 12-15, 1998. (Abstract 480). Losso M, Belloso WH, Benetucci JA, Cahn PE, Lasala MC, Lopardo G, Salomon H, Saracco M, S. Emery, Allende MC, Law MG, Davey RT, , Lane C. Evaluation of subcutaneous interleukin-2 plus antiretroviral therapy vs. antiretrovirals alone in patients with HIV-1 infection and CD4+ cell count (350/mm3. 6th Conference on Retrovirus and Opportunistic Infections. Chicago, IL, USA. January 31-February 4, 1999. (Abstract 354). Podesta O, Romero R, Llambias P, Galdon F, Scilingo V, Marin M, Lopardo G, Stamboulian D. Estudio prospectivo para la deteccin de pacientes colonizados con enterococo resistente a la vancomicina (ERV) en una unidad de cuidados intensivos. IX Congreso Panamericano de Infectologa. API 1999. Ciudad de Guatemala, Guatemala, May 3-7, 1999. Losso M, Belloso WH, Benetucci JA, Cahn PE, Lasala MC, Lopardo G, Salomon H, Saracco M, Emery J, L Fosdick, Allende MC, Davey RT, , Lane C. Vanguard Study Group. Twenty month follow up of the Argentina Vanguard study: A randomized, controlled, phase II trial of intermitent interleukin-2 (scIL2) plus antiretroviral therapy (ARV) vs. ARV alone. 7th Conference on Retrovirus and Opprtunistic Infections. San Francisco, CA, USA. January 30-February 2, 2000. (Abstract 380). Barcelona L, Lopardo G, Debbag R, Lazovski J, Bugarin G, Stamboulian D. Developing outpatient parenteral antimicrobial therapy (OPAT) programs: the experience of an ID team in Argentina. 9th International Congress on Infectious Diseases, Buenos Aires, Argentina. April 10-13, 2000. (Abstract 44016) Belloso W, Lopardo G, Ivalo s, Ishida S, Tessler J, Barcan L, Cassetti I, Stern L, Clara L. Lipodystrophy syndrome: predicting factors for body fat redistribution. 9th International Congress on Infectious Diseases, Buenos Aires, Argentina. April 10-13, 2000. (Abstract 78020) Nacinovich F, Lopardo G, Daher J, Stamboulian D. Laryngeal histoplasmosis in HIV positive patients. 14th Congress of thye International Society for Human and Animal Mycology. May 8-12, 2000. Buenos Aires, Argentina. Grazziutti M, Belloni R, Fridman D, Barcelona L, Tronge P, Lopardo G*, Stamboulian D Sepsis due to Capnocytophaga ochracea: case presentation.. Pan American Association of Infectious Diseases. X Pan American Congress, Guadalajara, Mexico. May 1-5, 2001. Lopardo G, Goldenberg F, Perez a, Abalo S, Belloni R, Fridman D, Rodriguez Vivie H, Saenz C, Gross P, Galdon F, Stamboulian D. Eficacy of non-broncoscopic lavage for the diagnosis of ventilator associated pneumonia. Pan American Association of Infectious Diseases. X Pan American Congress, Guadalajara, Mexico. May 1-5, 2001. Bottaro E, Laurido M, Caiafa D, Bugarin G, Pascual A, Lopardo G, Cassetti I. Switching protease inhibitors in non-failing HIV+ patients. The 1st IAS Conference on HIV pathogenesis and treatment. July 8-11, 2001, Buenos Aires, Argentina Cassetti I, Montes J, Pascual A, Lopardo G, Bottaro E, Lazovski J, Stamboulian D. Preliminary results from the lopinavir/ritonavir early-access program. The 1st IAS Conference on HIV pathogenesis and treatment. July 8-11,2001 Buenos Aires, Argentina Belloso W, Consiglio E, Lopardo G, Chiocconi E, Etchegoyen M, Amin M, Tessler J. Quality of life instrument development in Argentinian HIV+ population (preliminary report). The 1st IAS Conference on HIV pathogenesis and treatment. July 8-11,2001 Buenos Aires, Argentina Bottaro E, Urquiza A, Caiafa D, Trinidad P, Lopardo G, Cassetti I. Stopping suppressive therapy for opportunistic infections: a safe strategy. XIV International AIDS Conference 2002, July 7-12, Barcelona, Spain. Lopardo G, Fridman D, Gonzlez Arzac M, Calmaggi A, Smayevsky J, Podest O, Clara L. Infeccin urinaria no complicada: bajos porcentajes de resistencia a trimetoprima-sulfametoxazol en la ciudad de Buenos Aires. XI Congreso Panamericano de Infectologa, Crdoba, Argentina, May 11-14, 2003. Rodrguez Iantorno P, Elmassian P, Fridman D, Lopardo G, Podest O, Stamboulian D. Anlisis epidemiolgico de las bacteriemias en una institucin de la ciudad de Buenos Aires en la actualidad. XI Congreso Panamericano de Infectologa, Crdoba, Argentina, May 11-14, 2003. Sarubbi M, Vazquez L, Ortiz de Zrate M, Rodrguez C, Caete G, Luppino V, Carranza C, Galimberti D, Garca F, Sturba E, Lopardo G, Stamboulian D. Perinatal HIV infection: results of a vertical transmission prevention program (AMAPES). 2nd IAS Conference on HIV pathogenesis and Treatment. Paris July 13-16, 2003. Bottaro EG, Figueroa R, Scapellato PG, Vidal GI, Rodriguez Brieschke MT, Laurido MF, Caiafa D, Lopardo G, Herrera F, Cassetti I. Osteonecrosis en pacientes con SIDA: presentacin de una serie. 6( Congreso Argentino de SIDA. Buenos Aires November 20-23, 2003. Lopardo G, Bugarin G, Fridman D, Elmassian P, Spina Pea M, Huberman M. Seguridad de la rifampicina como parte del tratamiento de la tuberculosis en pacientes HIV reactivos con HAART. 6( Congreso Argentino de SIDA. Buenos Aires May 20-23, 2003. Belloso WH, Consiglio E, Quirs RE, Lopardo G, Chiocconi E, Martins M, Woloski P, Sanchez M. Desarrollo de un cuestionario especfico de calidad de vida para pacientes con infeccin por HIV (proyecto CV AR). 6( Congreso Argentino de SIDA. Buenos Aires November 20-23, 2003. Lopardo G. Bugarin G., Fridman D., Elmassian P., Espina Pea M., Huberman M., Cassetti I., Stamboulian D. Seguridad y eficacia del tratamiento de tuberculosis con regmenes que incluyen rifampicina ms terapia antirretroviral de alta eficacia. Abstract 141. IV Congreso Argentino de Infectologa. Mar del Plata May 7-9, 2004 Vizzotti C., Espina Pea M., Lopardo G., Fridman D., Vazquez L., Stamboulian D. Sndrome febril prolongado: importancia de la presentacin clnica inicial. Abstract 296. IV Congreso Argentino de Infectologa. Mar del Plata, May 7-9, 2004. Espina Pea M., Vizzotti C., Lopardo G., Fridman D., Vazquez L., Stamboulian D. Fiebre de origen desconocido: evaluacin de 104 pacientes que consultaron en un centro de infectologa ambulatorio de la ciudad de Buenos Aires. Abstract 297. IV Congreso Argentino de Infectologa. Mar del Plata May 7-9, 2004. Vizzotti C., Lopardo G., Espina Pea M., Crespo A., Fridman D., Vazquez L., Stamboulian D. Sfilis: formas de presentacin en pacientes co-infectados y no co-infectados con VIH. V Congreso Argentino de Infectologa. Mar del Plata May 6-8, 2005. Petroni A., Deluchi G., Bortolizzi R., Garone D., Lopardo G., Pryluka D., Rodrguez C., Calan L., Lazaro M., Maranzana A., Puga L., Benetucci J. Update on primary HIV-1 resistance in Argentina: the first report of mutations conferring high-level resistence to non-nucluoside reverse transcripatase inhibitors (NNRTI) in drug-nave patients. 3rd IAS Conference on HIV pathogenesis and treatment. Rio de Janeiro July 24-27, 2005 Guzzi L, Latorraca M, Bassuk A, Barcelona L, Lopardo G Meningitis por Streptococcus bovis secundaria a endocarditis infecciosa: una complicacin poco frecuente. XVI Congreso Nacional de Medicina. November 21-24, 2005, Buenos Aires, Argentina Belloso WH, Snchez ML, Ajzenszlos MR, Otegui IM, Lopardo GD, Galich AM, Delfante A, UGT S, Rey R, Clara LO. Impacto de un programa de nutricin y ejercicio sobre parmetros de riesgo cardiovascular en pacientes con lipodistrofia (Estudio LUNES). Abstract 194. Resultados preliminares. VII Congreso Argentino de SIDA. November 24-26, 2005, La Plata, Argentina Vizzotti C, Lopardo G, Espina Pea M, Crespo A, Fridman D, Bugarin G, Cassetti I. Sfilis: formas de presentacin en pacientes co-infectados con VIH y no co-infectados. Abstract 288. Resultados preliminares. VII Congreso Argentino de SIDA. November 24-26, 2005, La Plata, Argentina Buono M, Barcelona L, Faras A, Crivelli C, Lopardo G. Endocarditis infecciosa por Pseudomonas aeruginosa en vlvula nativa no asociada a adiccin I.V. Abstract 151. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina Lopardo G, Fridman D, Cassetti I. Psicosis aguda inducida por efavirenz. Resumen 188. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina Lopardo G, Benchetrit G, Corral J, De Vedia L, Gonzlez J, Luna C, Martnez J, Marzoratti L, Rodrguez E, Rodrguez M, Victorio C, Videla A, Barcelona L, Bissio E, Peyrani P, Ramrez J. Evaluacin de los ndices de severidad en pacientes hospitalizados por neumona adquirida en la comunidad en 12 centros de Argentina. Abstract 189. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina Lopardo G, Benchetrit G, Corral J, De Vedia L, Gonzlez J, Luna C, Martnez J, Marzoratti L, Rodrguez E, Rodrguez M, Victorio C, Videla A, Barcelona L, Bissio E, Peyrani P, Ramrez J. Agentes etiolgicos de pacientes hospitalizados por neumona adquirida en la comunidad: alta sensibilidad de los hemocultivos. Abstract 222. VI Congreso Argentino SADI. May 5-6 2006, Mar del Plata, Argentina Lopardo G, Bissio E, Crespo A, Garone D, Bugara G. No se hallaron alteraciones en el funcionamiento neurocognitivo de pacientes VIH reactivos con inmunidad conservada, ni tampoco diferencias entre pacientes con inmunidad conservada recibiendo HAART o naive de tratamiento. Abstract 190. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina Lopardo G, Bissio E, Iannella M, Garone D, Crespo A, Cassetti I. No evidence of difference in neurological performance assessed by the International HIV dementia scale between patients with preserved immunity with and without HAART. THPE0074. XVI International AIDS Conference. August 13-18, 2006, Toronto, Canada Belloso WH, Snchez ML, Otegui IM, Ajzenszlos MR, Galich AM, UGT S, Lopardo G, Brites F, Delfante A, Rey R, Torres D, Clara LO. Management of Lipodystrophy trough a program of supervised Nutrition and Exercise (LUNES Study). 8th International Workshop on Adverse Drug Reactions and Lipodystrophy. San Francisco USA, Sep 24-25, 2006. Abstract 97. Niccodemi C, Lopardo G, Guzzi L, Poggi E, Barcelona L, Garone D, Gonzalez J, Martinez J, Marzoratti L, Rodriguez E, Peyrani P, Christensen D, Ramirez J and members of CAPO Group. Diabetes mellitus no se asoci con peor pronstico en pacientes hospitalizados por neumona adquirida en la comunidad. VII Congreso Argentino de la Sociedad Argentina de Infectologa. Mar del Plata May 4-5, 2007. Oral presentation, Abstract 17620. Guzzi L, Lopardo G, , Poggi E, Niccodemi C, Barcelona L, Berdinas V, Benchetrit G, De Vedia L, Luna C, Peyrani P, Christensen D, Ramirez J and members of CAPO Group . Tratamiento antibitico de pacientes hospitalizados por neumona adquirida en la comunidad: la cobertura de grmenes atpicos no se asoci con beneficios. VII Congreso Argentino de la Sociedad Argentina de Infectologa. Mar del Plata May 4-5, 2007. Oral presentation, Abstract 17624. Poggi E, Lopardo G, Niccodemi C, Guzzi L, Barcelona L, Corral J, Rodrguez M, Victorio C, Videla A, Peyrani P, Christensen D, Ramirez J and members of CAPO Group. Estudio comparativo de la evolucin y tratamiento en pacientes hospitalizados por neumona adquirida en la comunidad en hospitales pblicos y privados. VII Congreso Argentino de la Sociedad Argentina de Infectologa. Mar del Plata May 4-5, 2007. Oral presentation, Abstract 17650. Bissio E, Lopardo G, Bugarn G. Incidencia de efectos adversos de atazanavir en la poblacin argentina. VII Congreso Argentino de la Sociedad Argentina de Infectologa. Mar del Plata May 4-5, 2007. Abstract 17539 Lopardo G, Guzzi L, Niccodemi MC, Espinola L, Lijavetzky A, Poggi E, Barcelona L, Benchetrit G, Gonzlez J, Videla A, Rodrguez M, Christensen D, Peyrani P, Ramrez J y grupo CAPO. Mayor frecuencia de bacteriemia en pacientes con neumona en Argentina en relacin con otras reas del mundo. VIII Congreso de la Sociedad Argentina de Infectologa. Mar del Plata. May 22-24,2008. Oral sessionl. Abstract 22899 Niccodemi MC, Lopardo G, Lijavetzky A, Guzzi L, Poggi E, MC, Espinola L, Barcelona L, De Vedia L, Martnez J, Marzoratti L, Victorio C, Peyrani P, Ramrez J y grupo CAPO. EPOC no se asoci con mayor mortalidad en pacientes hospitalizados con neumona adquirida en la comunidad. VIII Congreso de la Sociedad Argentina de Infectologa. Mar del Plata. May 22-24,2008. Oral session. Abstract 22887 Espinola L, Lopardo G, Niccodemi MC, Guzzi L, Poggi E, Lijavetzky A, Barcelona L, Luna C, Rodrguez E, Corral J, Peyrani P, Ramrez J. Mortalidad en pacientes con neumona provenientes de geritrico: estudio caso-control. VIII Congreso de la Sociedad Argentina de Infectologa. Mar del Plata. May22-24,2008. Oral session. Abstract 22894. Award. A Petroni, G Delucchi, G Lopardo, I Zapiola, D Pryluka, M Lazaro, E Chiocconi, P Elmassian, H Mingrone, J Martinez, R Bertolozzi, J Benetucci. HUV resistance surveillance on recently infected drug-naive patients from Argentina. XVII International AIDS Conference. August. 3-8,2008. Mexico City Abstract TUPE0073 A. La Rosa, PR Abrao, Y Roldan, G Lopardo, O Sussman, M Castrillo, J Galindez, F Ticona, R Gutierrez, GL Italien, N Cure-Bolt, DB Pedral, Gender differences in metabolic profile and cardiovascular risk among latin American HIV infected patients on HAART. 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. London November 6th 2008. O Sussman, R Salazar, J Galindez, F Rangel, ML Castaeda, G Lopardo, GA Cunha, Y Roldan, P Mantilla, GL Italien, N Cure-Bolt, M Castrillo. Prevalence and determinants of metabolic sndrome among latin american HIV infected patients on HAART. RAPID II Study. 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. London November 6th 2008. Lopardo G, Guzzi L, Barcelona L, Peyrani P, Ramirez J. Severity of disease and presence of bacteriemia in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study. XIV Congreso de la Asociacin Panamericana de infectologa. Campos do Jordao. April 25-28,2009. Lopardo G, Guzzi L, Niccodemi MC, Peyrani P, Ramirez J. Severity of disease and non-streptococcus pneumoniae bacteriemia in hospitalized patients with community-acquired pneumonia: result from the CAPO international cohort study. XIV Congreso de la Asociacin Panamericana de infectologa. Campos do Jordao. . April 25-28,2009. Sosa Avila L M, Barcelona L, Vieyra G, Berdias V, Lopardo G. Endocarditis infecciosa por C. parapsilosis asociada a marcapaso definitivo. IX Congreso de la Sociedad Argentina de Infectologa, Mar del Plata. May 6-8,2009. Abstract 24718. Lopardo G, Espinola L, Bissio E, Gallego P, Lijavetzky A, Rojas Bonilla M, Stambulian M, Gadano A. El ayuno incrementa la concentraciones sricas de bilirrubina en pacientes que reciben atazanavir. IX Congreso de la Sociedad Argentina de Infectologa, Mar del Plata. May 6-8,2009. Abstract 24730. Apesteguia A, Repetto M, De AllJ, Gnocchi C, Lopardo G, Espinola L, Olmedo G. Coinfeccin pulmonar por pneumocistis jirovecii y citomegalovirus em pacientes com SIDA. IX Congreso de la Sociedad Argentina de Infectologa, Mar del Plata. May 6-8,2009. Abstract 24809. Pryluka D, Lopardo G, Daciuk L, Stecher D, Bonveh P. Hospitalizations for acute respiratory infection of health workers in the circulation of influenza A H1 N1 in Argentina. X Congreso de la Sociedad Argentina de Infectologa, Mar del Plata 13 y 14 de mayo de 2010.Abstract 26634 Titanti, P; Berdias, V; Ramos, J; Manevich, L; Barcelona, L; Rios, P; Lopardo, G. Impact of policy restrictions as part of an antimicrobial management program at a university hospital. X Congreso de la Sociedad Argentina de Infectologa, Mar del Plata 13 y 14 de mayo de 2010. Abstract 26835 Monserrat, M; Bissio, E; Lopardo, G. Severe anemia and leukopenia associated with lamivudine, a rare adverse effect. XV Congreso Panamericano de Infectologa, Punta del Este 7 al 11 de abril de 2010. Abstract SP1A-004 Lopardo, G; Bissio, E; Peyrani, P; Ramirez, J; Grupo CAPO. Early initiation of antibiotics in patients with bacteremic pneumonia was associated with increased mortality. XI Congreso de la Sociedad Argentina de Infectologa, Mar del Plata 19 y 20 de mayo de 2011. Abstract 29126 Lopardo, G; Bissio, E; Peyrani, P; Ramirez, J; Grupo CAPO. The use of macrolides was associated with lower mortality in patients with bacteremic pneumonia. XI Congreso de la Sociedad Argentina de Infectologa, Mar del Plata 19 y 20 de mayo de 2011. Abstract 29129 Confalonieri V, Monczor A, Mozun F, Monserrat M, Tempelsman R, Copertari G, Ferraris A, Stamboulian D, Lopardo G. Reemergencia de sfilis: experiencia de un centro de la ciudad de Buenos Aires. XII Congreso de la Sociedad Argentina de Infectologa, Crdoba 16 a 18 de mayo de 2012. Abstract 29781 Monserrat M, Korin J, Mattos N, Schutz N, Lopadro G. Enfermedad de Castleman multicntrica con falla multiorgnica asociada a sarcoma de Kaposi con compromiso linfoganglionar en un paciente HIV reactivo. XII Congreso de la Sociedad Argentina de Infectologa, Crdoba 16 a 18 de mayo de 2012. Abstract 29742. Monserrat M, Bissio E, Lopardo G. Anemia, leucopenia severas asociadas a lamivudina, un efecto adverso infrecuente. XII Congreso de la Sociedad Argentina de Infectologa, Crdoba 16 a 18 de mayo de 2012. Abstract 29754 Lopardo G, Guzzi L, Gentile J, Martins M, Saenz C, Fridman D, Stamboulian D. Hospitalizaciones por neumona adquirida en la comunidad en adultos en un periodo de tres aos en tres hospitales de Argentina XII Congreso de la Sociedad Argentina de Infectologa, Crdoba 16 a 18 de mayo de 2012. Abstract 29800. Copertari G, Tempelsman R Monserrat M, Monczor A, Mozun F, Confalonieri V, Ferraris A, Stamboulian D, Lopardo G. Reemergencia de sfilis: caractersticas clnicas y epidemiolgicas en pacientes coinfectados con VIH y no coinfectados. XII Congreso de la Sociedad Argentina de Infectologa, Crdoba 16 a 18 de mayo de 2012. Abstract 29770 Lopardo G, Fridman D, Raimondo E, Stamboulian D. Prospective population-based surveillance to determine the incidence of community-acquired pneumonia among adults, General Roca city, Ro Negro, Argentina. II Conference on Controversies in Vaccination in Adults. 14 a 17 febrero 2012, Munich, Alemania. Nacinovich F, Ruttimann R, Bonveh P, Giglio N, Lopardo G, Stamboulian D. Burden of Community-acquired pneumonia (CAP) in Argentina. 8th International Symposium on Pneumoccici and Pneumococcal Disease. Foz do Iguazu, Brazil. 11 a 15 de marzo de 2012 Lopardo G, Noriega F, Zambrano B, Rivas E. Incidence of Clostridium difficile infections in adults at-risk hospitalized in four large centers in Latin America. XIV Congreso Panamericano de Infectologa, Santiago de Chile, 28 de mayo al 1 de junio de 2013. Lopardo G, Ortiz E; Morfin M, Moran I, Noriega F, Zambrano B, Luxemburger C, Rivas E. Incidencia de diarrhea asociada a infeccin por Clostridium difficile en pacientes adultos hospitalizados en cuatro centros de Amrica Latina. XIII Congreso Argentino de Infectologa, Mar del Plata, 9 al 11 de junio de 2013. Lopardo G, Fridman D, Raimondo E, Stamboulian D. Estudio prospectivo de vigilancia epidemiolgica de neumona adquirida en la comunidad en adultos en la ciudad de General Roca, provincia de Ro Negro, Argentina. XIII Congreso Argentino de Infectologa, Mar del Plata, 9 al 11 de junio de 2013. Monczor A, Confalonieri V, Monserrat M, Mozun Tamborenea F, Cisneros V, Tempelsman R, Copertari G, Ferraris A, Lopardo G. Durabilidad del primer esquema de tratamiento antirretroviral y motivos de cambio en una cohorte de personas viviendo con VIH. XIII Congreso Argentino de Infectologa, Mar del Plata, 9 al 11 de junio de 2013. Lopardo G, Fridman D, Raimondo E, Bagnulo H, Albornoz H, Goleniuk D, Sanabria M, Baez E, Stamboulian D. Preliminary results of a prospective population-based surveillance burden of community-acquired pneumonia in adults, in the South Cone of Latin-America. 9th International Symposium on Pneumoccici and Pneumococcal Disease. Hyderabad, India. 9 al 13de marzo de 2014 B. Papers Jayaweera DT, Cassetti LI, Espinoza L; Lopardo G, Hansman-Whiteman ML, Scerpella EG. Poliradiculomielopatia causada por Citomegalovirus en pacientes con SIDA. Medicina (Buenos Aires)1998;58:135-140. Losso M, Belloso WH, Emery S, Benetucci JA, Cahn PE, Lasala MC, Lopardo G, Salomon H, Saracco M, Nelson E, Law MG, Davey RT, Allende MC, Lane C. A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell count (350/mm3. J Infect Dis 2000;181:1614-1621. Gustavo Lopardo. Management of Endocarditis: Outpatient Parenteral Antibiotic Treatment in Argentina. Chemotherapy 2001;(suppl 1):24-32 Marin ME, Podesta O, Llambias P, Galdon F, Scilingo VM, Stamboulian D, Romero RH, Lopardo GD. Detection of carriage of vancomycin-reistant enterococci in an intensive care unit in Buenos Aires. Infect Control Hosp Epidemiol 2001 Jun;22(6):332-3 Lopardo G, Sturba E, Martinez ML, Roel JE, Gamba A, Biondi H, Stamboulian D. Deteccin de infeccion aguda por Legionella pneumophila en pacientes con Neumona Adquirida en la Comunidad en la Ciudad de Buenos Aires. Medicina (Buenos Aires) 2002;62:145-148. Bottaro EG, Figueroa RH, Scapellato PG, Vidal GI, Rodrguez Brieschke MT, Da Representacao S, Seoane MB, Laurido M, Caiafa D, Lopardo G, Herrera F, Cassetti I. Osteonecrosis in HIV-infected patients. Medicina (Buenos Aires) 2004;64:325-31 Consenso de Endocarditis Infecciosa. Colaborador Revista Argentina de cardiologa 2002; Vol 70, Sup 5. Petroni A, Deluchi G, Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, Bouzas M, Zapiola I, Garone D, Rodrguez C, Chiocconi E, Lzaro M, Murano F, Maranzana A, Oliva S, Aparicio M, Beltrn M and. Benetucci J. Update on Primary HIV-1 Resistance in Argentina: Emergence of Mutations Conferring High-Level Resistance to Non-nucleoside Reverse Transcriptase Inhibitors in Drug-Naive Patients. J Acquir Immune Deficit Syndr 2006;42:506-510 Lopardo G, Fridman D, Gonzalez Arzac M, Calmaggi A, Smayevsky J, Podest O, Clara L. Uropathogen resistance: are laboratory-generated data reliable enough? J Chemother 2007;19:33-7 Diana Christensen, Carlos Luna, Jorge Martinez, Eduardo Rodrguez, Lucia Marzoratti, Jos Gonzalez Alejandro Videla, Lautaro De Vedia, Jorge Corral, Guillermo Benchetrit, Maria Rodrguez, Carlos Victorio, Gustavo Lopardo, Paula Peyrani, Julio Ramrez. Cumplimiento con las guas nacionales en pacientes hospitalizados con neumona adquirida en la comunidad. Medicina (Buenos Aires) 2007;67:709-713 Aliberti S, Myers JA, Peyrani P, Blasi F, Menendez R, Rossi P, Cosentini R, Lopardo G, de Vedia L, Ramirez J.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/18829671?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum" The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia. Eur Respir J. 2009 Jan;33(1):142-7. Epub 2008 Oct 1. Lopardo G, Bissio E, Iannella MC, Crespo A; Garone D, Cassetti L. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection. J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):488-92. Malinis M, Myers J, Bordon J, Peyrani P, Kapoor R, Nakamatzu R, Lopardo G, Torres A, Feldman C, Allen M, Arnold F, Ramirez J.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/19586789?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=5" Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis. 2009 Jul 6. [Epub ahead of print] Forest W Arnold1, DO, A. Scott LaJoie2, PhD, Paula Peyrani1, MD, Jordi Rello3, MD, Rosario Menndez4, MD, Gustavo Lopardo5, MD, Antoni Torres6, MD, Paolo Rossi7, MD, Julio A, Ramirez1, MD and the CAPO investigators "Improving Outcomes in Elderly Patients with Community-Acquired Pneumonia by Adhering to National Guidelines", will be in the Sept 14, 2009. Arch Intern Med. 2009 Sep 14;169(16):1515-24. INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lvy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/19828532?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2" Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 2009 Oct 15;361(16):1548-59. Aliberti S, Brock GN, Peyrani P, Blasi F, Ramirez JA; Community-Acquired Pneumonia Organization.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/19919775?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1" The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2009 Dec;13(12):1550-6. Tavel JA; INSIGHT STALWART Study Group, Babiker A, Fox L, Gey D, Lopardo G, Markowitz N, Paton N, Wentworth D, Wyman N.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/20186278" Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study. PLoS One. 2010 Feb 23;5(2):e9334 Stamboulian D, Lopardo G, Lopez P, Cortes-Barbosa C, Valencia A, Bedell L, Karsten A, Dull PM  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/20655261" Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America. Int J Infect Dis. 2010 Int J Infect Dis. 2010 Oct;14(10):e868-75 Bantar C, Curcio D, Jasovich A, Bagnulo H, Arango A, Bavestrello L, Famiglietti A, Garca P, Lopardo G, Losanovscky M, Martnez E, Pedreira W, Pieyro L, Remolif C, Rossi F, Varn F  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/20737129" Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II). Rev Chilena Infectol. 2010 Jun;27 Suppl 1:S9-S38. Alvarez C, Salazar R, Galindez J, Rangel F, Castaeda ML, Lopardo G, Cuhna CA, Roldan Y, Sussman O, Gutierrez G, Cure-Bolt N, Seas C, Carcamo C, Castrillo M.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/20835509" Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America. Braz J Infect Dis. 2010 May-Jun;14(3):256-63. Arnold FW, Brock GN, Peyrani P, Rodrguez EL, Daz AA, Rossi P, Ramirez JA; CAPO authors  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/20576417" Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med. 2010 Nov;104(11):1736-43. Corey GR, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T; CANVAS 1 investigators.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/21115454" CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv41-51 Riquelme R, Jimnez P, Videla AJ, Lopez H, Chalmers J, Singanayagam A, Riquelme M, Peyrani P, Wiemken T, Arbo G, Benchetrit G, Rioseco ML, Ayesu K, Klotchko A, Marzoratti L, Raya M, Figueroa S, Saavedra F, Pryluka D, Inzunza C, Torres A, Alvare P, Fernandez P, Barros M, Gomez Y, Contreras C, Rello J, Bordon J, Feldman C, Arnold F, Nakamatsu R, Riquelme J, Blasi F, Aliberti S, Cosentini R, Lopardo G, Gnoni M, Welte T, Saad M, Guardiola J, Ramirez J.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/21396216" Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Dwyer DE; INSIGHT Influenza Study Group. Vaccine. 2011 Jul 22;29 Suppl 2:B56-62.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/21757105" Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies. Lopardo G, Titanti P, Berdias V, Barcelona L, Curcio D.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/22358421" Antimicrobial stewardship program in a developing country: the epidemiological barrier. Rev Panam Salud Publica. 2011 Dec;30(6):667-8. No abstract available. Markowitz N, Lopardo G, Wentworth D, Gey D, Babiker A, Fox L, Tavel J; STALWART Study Group.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23082173" Long-term effects of intermittent IL-2 in HIV infection: extended follow-up of the INSIGHT STALWART Study. PLoS One. 2012;7(10):e47506. doi: 10.1371/journal.pone.0047506. Epub 2012 Oct 17. Lopardo G, Bissio E, Espinola L, Gallego P, Stambullian M, Gadano A.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23113663" Fasting Increases Serum Concentrations of Bilirubin in Patients Receiving Atazanavir: Results from a Pilot Study. AIDS Res Hum Retroviruses. 2012 Oct 31. [Epub ahead of print] Bissio E, Lopardo GD.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23121190" Incidence of Hyperbilirubinemia and Jaundice Due to Atazanavir in a Cohort of Hispanic Patients. AIDS Res Hum Retroviruses. 2012 Nov 28. [Epub ahead of print] No abstract available. Lopardo G, Calmaggi A, Clara L, Levy Hara G, Mykietiuk A, Pryluka D, Ruvinsky S, Vujacich C, Yahni D, Bogdanowicz E, Klein M, Lpez Furst MJ, Pensotti C, Rial MJ, Scapellato P.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23241293" [Consensus guidelines for the management of upper respiratory tract infections]. Medicina (B Aires). 2012;72(6):484-94. Spanish Pryluka D, Lopardo G, Daciuk L, Stecher D, Bonvehi P.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23324818" Severe acute respiratory disease in health-care workers during the influenza H1N1 pandemic in Argentina.J Infect Dev Ctries. 2013 Jan 15;7(1):36-40. Davey RT Jr, Lynfield R, Dwyer DE, Losso MH, Cozzi-Lepri A, Wentworth D, Lane HC, Dewar R, Rupert A, Metcalf JA, Pett SL, Uyeki TM, Bruguera JM, Angus B, Cummins N, Lundgren J, Neaton JD; INSIGHT FLU 002 & 003 Study Groups.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23468921" The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One. 2013;8(2):e57121. doi: 10.1371/journal.pone.0057121. Epub 2013 Feb 27 Lopardo G, Pensotti C, Scapellato P, Caberlotto O, Calmaggi A, Clara L, Klein M, Levy Hara G, Lpez Furst MJ, Mykietiuk A, Pryluka D, Rial MJ, Vujacich C, Yahni D.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23570768" [Inter-society consensus for the management of respiratory infections: acute bronchitis and chronic obstructive pulmonary disease]. Medicina (B Aires). 2013;73(2):163-73. Spanish. Saira K, Lin X, DePasse JV, Halpin R, Twaddle A, Stockwell T, Angus B, Cozzi-Lepri A, Delfino M, Dugan V, Dwyer DE, Freiberg M, Horban A, Losso M, Lynfield R, Wentworth DN, Holmes EC, Davey R, Wentworth DE, Ghedin E; INSIGHT FLU002 Study Group; INSIGHT FLU003 Study Group.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23678180" Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J Virol. 2013 Jul;87(14):8064-74. doi: 10.1128/JVI.00240-13. Epub 2013 May 15 Boyd MA, Kumarasamy N, Moore CL, Nwizu C, Losso MH, Mohapi L, Martin A, Kerr S, Sohn AH, Teppler H, Van de Steen O, Molina JM, Emery S, Cooper DA. SECOND-LINE Study Group .  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/23769235" Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study., Lancet. 2013 Jun 15;381(9883):2091-9. doi: 10.1016/S0140-6736(13)61164-2. Lpez Furst MJ, de Vedia L, Fernndez S, Gardella N, Ganaha MC, Prieto S, Carbone E, Lista N, Rotryng F, Morera GI, Mollerach M, Stryjewski ME; Grupo de Estudio de Infecciones de Piel y Estructuras Relacionadas por Staphylococcus aureus meticilino-resistente de la Comunidad, Sociedad Argentina de Infectologa.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/24324543" Prospective multicenter study of community-associated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus in Buenos Aires, Argentina. PLoS One. 2013 Nov 20;8(11):e78303. doi: 10.1371/journal.pone.0078303. eCollection 2013 Lopardo G, Yahni D.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/24356278" On the role of groups C and G streptococci in acute pharyngitis. Medicina (B Aires). 2013;73(6):606. Spanish. No abstract available Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F, Fernandez-Gonzalez R, Lopardo G, Ramirez JA; CAPO Investigators. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Vaccine. 2014 Apr 17;32(19):2198-203. doi: 10.1016/j.vaccine.2014.02.048. Epub 2014 Mar 6 Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD; INSIGHT SMART Study Group; ESPRIT Study Group; SILCAAT Scientific Committee  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/24626096" Factors associated with D-dimer levels in HIV-infected individuals. PLoS One. 2014 Mar 13;9(3):e90978. doi: 10.1371/journal.pone.0090978. eCollection 2014 Leda Guzzi, Gustavo Lopardo, Lidia Espinola, Mara Cecilia Niccodemi, Laura Barcelona, Julio Ramrez y grupo CAPO. Mortalidad en pacientes con neumona provenientes de geritrico: estudio caso-control. Rev Am Med Resp 2013;3 :133 -139 Nordell AD, McKenna M, Borges H, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/24870935" Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844. Lynfield R, Davey R, Dwyer DE, Losso MH, Wentworth D, Cozzi-Lepri A, Herman-Lamin K, Cholewinska G, David D, Kuetter S, Ternesgen Z, Uyeki TM, Lane HC, Lundgren J, Neaton JD; INSIGHT Influenza Study Group.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/25004134" Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies. PLoS One. 2014 Jul 8;9(7):e101785. doi: 10.1371/journal.pone.0101785. eCollection 2014. Lopardo G, Morfin-Otero R, Moran-Vazquez II, Noriega F, Zambrano B, Luxemburger C, Foglia G, Rivas EE.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/25179510" Epidemiology of Clostridium difficile: a hospital-based descriptive study in Argentina and Mexico. Braz J Infect Dis. 2014 Aug 29. pii: S1413-8670(14)00167-6. doi: 10.1016/j.bjid.2014.07.004. [Epub ahead of print] PMID:25179510 [PubMed - as supplied by publisher] INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Lundgren J, Babiker A, Gordin F, Emery S, Ftkenheuer G, Molina JM, Wood R, Neaton JD.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/25711317" Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Med. 2015 Apr;16 Suppl 1:1-9. doi: 10.1111/hiv.12227. No abstract available. Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/25826420" Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/26424460" Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis. Boyd MA, Moore CL, Molina JM, Wood R, Madero JS, Wolff M, Ruxrungtham K, Losso M, Renjifo B, Teppler H, Kelleher AD, Amin J, Emery S, Cooper DA; SECOND-LINE study group. Lancet HIV. 2015 Feb;2(2):e42-51. doi: 10.1016/S2352-3018(14)00061-7. Epub 2015 Jan 20.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/26339883" [Guidelines for management of community-acquired pneumonia in adults]. Lopardo G, Basombro A, Clara L, Desse J, De Vedia L, Di Libero E, Gaete M, Lpez Furst MJ, Mykietiuk A, Nemirovsky C, Osuna C, Pensotti C, Scapellato P. Medicina (B Aires). 2015;75(4):245-57.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/26192873" Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Ftkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD. N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20 BOOKS Lopardo G. Home therapy in Infectious diseases. In: Stamboulian D. Infectologa para la prctica diaria. Eds FUNCEI, Fundacin del Centro de Estudios Infectolgicos, Buenos Aires, 1995. 51-69. Cassetti I, Lopardo G. y col. Infectologa, captulo 16. En: Sanguinetti CA y col. Semiologa, Semiotecnia y Medicina Interna. 7( edicin. Eds. Lpez Libreros, Buenos Aires, 1998 Lopardo G. Diagnosis and Treatment of Uncomplicated Urinary Tract Infections. In Stamboulian D. Temas de Infectologa Clnica. Eds. McGraw-Hill, Buenos Aires,2002.159-175. Nacinovich F, Lopardo G, StamboulianD. Infecciones. In Trong Jorge. Emergencias Cardiovasculares en el Geronte. Eds Cesarini Hnos, Buenos Aires, 2002.311-333.. Lopardo Gustavo. Enfermedades de transmisin sexual. En: Paganini Hugo R. Infectologa Peditrica, 1( edicin Eds Cientfica Interamericana S.A.C.I., Buenos Aires, 2007: 466-475 Lopardo Gustavo. Hacia el control de la epidemia. En: Waldo H. Belloso, Esteban Martnez. La era del SIDA, 100 preguntas. 1 ed. Buenos Aires: delhospital ediciones, 2013, pginas 98-106 EXPERIENCES IN CLINICAL INVESTIGATION 2001 Course Metodologa de la Investigacin, Academia Nacional de Medicina, including training in Good Clinical Practice. 2003 Curso de formacin de investigadores clnicos. Prof. Dr. Jos Tessler, 145 hours, including training in Good Clinical Practice. Co-Investigator in the study Zalcitavine in combination with zidovudine for the treatment of advanced HIV disease. Protocol number M50002, 1994. Co-Investigator in the study Face III controlled double blinded randomized multinational study for the preventive therapy of latent tuberculosis in HIV positive individuals: isoniacid (300mglday per 12 months) vs. Rifabutine (300mglday per 3 months). 1995. Co-Investigator in the study: An international, multicenter, open-label, non-comparative trial of recombinant-methionyl human granulocyte colony stimulating factor (r-metHuG-CSF, filgrastim) for reversal of neutropenia in patients with HIV infection. 1993. Co-Investigator in the study: Face II-III study, multicentric, non comparative, open label for the treatment with oral gatifloxacina for community adquired pneumonia. Protocol number A1420-003. 1997. Principal Investigator in: A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell count (350/mm3. National institute of Health. 1997. Co-Investigator in the study: Face II-III study an open-label, multicenter study of clinafloxacin in the treatment of infective endocarditis. Parke Davis. 1998 Co-Investigator in the study phase IIIB/IV clinical trial protocol a multiinvestigator comparative study of cefepime versus broad spectrum antibacterial therapy: empiric therapy in moderate and severe presumed bacterial infections. Bristol Myers Squibb. 2000 Principal Investigator in the study: A prospective, multicenter, double-blinded, randomized, comparative study to evaluate the safety, tolerability, and efficacy of MK-0826 versus piperacillin/tazobactam in the treatment of complicated skin and skin structure infections in adults. Protocol number 016-01, MSD. 1999 Principal Investigator in the study: A prospective, multicenter, double-blinded, randomized, comparative study to evaluate the safety, tolerability, and efficacy of MK-0826 versus ceftriaxone in the treatment of severe community-acquired pneumonia in adults.. Protocol number 018-00, MSD. 1999 Principal Investigator in the study: A prospective, multicenter, double-blinded, randomized, comparative study to evaluate the safety, tolerability, and efficacy of MK-0826 versus cefepime in the treatment of hospital-acquired pneumonia in adults.. Protocol number 025-00 MSD. 1999-2001 Principal Investigator in. A randomized, double-blind, multicenter, comparative, phase III study of 5-day oral BMS-284756 versus oral amoxicillin/clavulanate in the treatment of mild to moderate community acquired pneumonia. Phase III, Bristol Myers Squibb. 2001 Principal Investigator in the study: Surveillance of resistance in non complicated urinary tract infecton pathogens. Sponsored by VIGIA program. Ministry of Public Health and Banco Interamericano de Desarrollo (BID). 2001. Principal Investigator in the study A phase III multicenter randomized study of the biological and clinical efficacy of subcutaneous recombinant, human interleukin-2 in HIV-infected patients with low CD4 counts under active antiretroviral therapy (SILCAAT). Chiron. 2000, ongoing. Principal Investigator in the study A randomized, open-label, phase III, international study of subcutaneous recombinant IL-2 (Proleukin) in patients with HIV-1 infection and CD4 cell count (300/mm3: evaluation of subcutaneous proleukin in a randomized international trial (ESPRIT). National Institute of Health. 2000-2008 Principal Investigator in the study Assessment of resistance in urinary tract pathogens causing uncomplicated urinary tract infections. Sponsored by VIGI+A Ministry of Public Health, Argentina. 2001 Principal Investigator in the study A phase III multicenter randomized study of the biological and clinical efficacy of subcutaneous recombinant, human interleukin-2 in HIV-infected patients with low CD4 counts under active antiretroviral therapy (SILCAAT). Chiron. 2000-2008. Principal Investigator in the study Phase III Multicenter Study to confirm safety and efficacy of IV doripenem to treat complicated urinary tract infections and pyelonephritis , 2004-2005 Principal Investigator in the study Dobre blinded, multicenter, randomized, phase III study to compare safety and efficacy of IV doripenem in treatment of complicated abdominal infections. Peninsula, 2004-2005 Co-Investigador in the study Manejo de lipodistrofia mediante un programa nico de nutricin y ejercicio supervisado en pacientes con infeccin por HIV (Estudio LUNES). Co-Investigator in the study Strategies for Management of Anti-Retroviral Therapy (SMART) sponsored by the Divisssion of AIDS of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, 2004-2006 Principal Investigator in the study -RO 4908463 Un estudio de prueba de concepto, de grupos paralelos, controlado por comparador activo, doble ciego, randomizado, prospectivo, Fase II en pacientes adultos con neumona adquirida en la comunidad que requieren hospitalizacin, sin evidencia alguna de Legionella. (CAPTURE) Roche, 2005 Principal Investigator for Argentina and member of the International steering committee for the study; A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 (rIL-2, Aldesleukin) with and without Concomitant Antiretroviral Therapy in Patients with HIV-1 Infection and CD4+ Cell Counts e" 300/mm3: Study of Aldesleukin with and without Antiretroviral Therapy (ESPRIT 002: STALWART), ongoing. Principal Investigator  Multicenter, Randomized phase III Study to compare Safety and Efficacy of intravenous doripenem with intravenous piperacillin-tazobactam in patients with hospital-acquired pneumonia.. DORI 09. Janssen Cilag, 2006 Principal Investigator Multicenter, Randomized, doubl blind phase III Study to compare safety and efficacy of intravenous ceftarolina with intravenous vancomycin-aztreonam in patients with complicated soft and skin tissue infections. Janssen-Cilag P903-06, 2007 Subinvestigador in Multicenter, Randomized blind phase III study to compare immunogenicity And safety of antimeningococcal conjugated vaccinea ACWY-Novartis with MenactraTM and Menomune. Protocol study V59P17. Novartis Vaccines & Diagnostics, Inc. 2007 Principal Investigator Multicenter, Randomized, Double Blind, phase III Study to compare safety and efficacy of intravenous ceftaroline with intravenous ceftriaxone in patients with community-acquired pneumonia. Janssen-Cilag P903-08, 2008 Principal Investigator in the Study START Strategic Timing of Anti-Retroviral Treatment. National Institute of Health. 2009-ongoing Principal Investigator Descriptive Edemiology of Clostridium difficile in Latin America (CDI02) Started in 2010-ongoing Investigator Initiative Research Principal Investigator in the study International Observational Study to Characterize Adults with Influenza A-H1N1 Pandemic (H1N1v) INSIGHT Outpatient Study H1N1 (FLU002), sponsored by the University of Minnesota, the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA (NIAID), ongoing. Principal Investigator in the study "International Observational Study to Characterize Hospitalized Adults with Complications of Influenza A-H1N1 Pandemic (H1N1v)" Inpatient Study INSIGHT H1N1 (FLU003), sponsored by the University of Minnesota, the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA (NIAID), ongoing. Principal Investigator in the epidemiological study to assess the incidence of diarrhea caused by Clostriidium difficile in a general hospital, sponsored by SANOFI-PASTEUR, September 2010 - August 2011 Principal Investigator in the study IRC 003: Un estudio doble ciego, aleatorizado, de fase 2 que compara la eficacia, seguridad y tolerabilidad deentre la combinacin de antivirales (amantadina, ribavirina, oseltamivir) cony oseltamivir para el tratamiento de la influenza en adultos con riesgo de complicaciones, patrocinado por los Institutos Nacionales de la Salud de los Estados Unidos (NIH). Hospital Bernardo Houssay, 2013 y FUNCEI 2014 Principal Investigator in the study IRC 004: Un estudio doble ciego, aleatorizado que compara oseltamivir con placebo para el tratamiento de la influenza en adultos con bajo riesgo, patrocinado por los Institutos Nacionales de la Salud de los Estados Unidos (NIH). Hospital Bernardo Houssay, 2013 Principal Investigator in the study ;LMNO]swɻɧp]G4$h 5CJ OJQJ\^JmH sH *h$h%15CJ OJQJ\^JmH sH $hx5CJ OJQJ\^JmH sH $h$h%1CJ OJQJ^JmH sH  h$h%1OJQJ^JmH sH $h$h%1CJ$OJQJ^JmH sH &h$h%15OJQJ\^JmH sH jh tUmHnHu h t5OJQJ\^JmH sH  hx5OJQJ\^JmH sH h%15OJQJ\mH sH  h%1CJ8-LMNOxyz$ @ v1$^va$$ @ v1$^va$gd$$ v1$^va$gd$  v^vgd$ $ v^va$$ v1$^va$wyz{ܯvcM>0hGh 5\mH sH h$5CJOJQJmH sH +hGh%15CJ OJQJ^JaJ mH sH %h=5CJ OJQJ^JaJ mH sH %h05CJ OJQJ^JaJ mH sH %hc5CJ OJQJ^JaJ mH sH %h^5CJ OJQJ^JaJ mH sH +hGhG5CJ OJQJ^JaJ mH sH ,jh$h$OJQJU^JmHnHuh%15CJOJQJmH sH 'h$h%15CJOJQJ^JmH sH z|}~ ^`gd $ @ v1$^va$ؿة{cM8 .htK^hx5:CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH +htK^h%15CJOJQJ^JaJmH sH .htK^h%15:CJOJQJ^JaJmH sH .htK^h~[5:CJOJQJ^JaJmH sH *htK^h~[5:CJOJQJ^JmH sH *htK^hx5:CJOJQJ^JmH sH 1jh~[6CJOJQJU^JmHnHsH u'htK^h%16CJOJQJ^JmH sH &htK^h%15OJQJ\^JmH sH  ;  7 8 : y z |   v1$^vgd  @  1$^ gd   1$^`gd $  1$^`a$gd $ @ v1$^va$ " 9 : к~~fQ9$(h%h%1CJOJQJ^JaJmH sH .h%h%15:CJOJQJ^JaJmH sH (h~[5:CJOJQJ^JaJmH sH .h~[hx5:CJOJQJ^JaJmH sH "h~[CJOJQJ^JaJmH sH (h~[h%1CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH +htK^h%15CJOJQJ^JaJmH sH .htK^h%15:CJOJQJ^JaJmH sH .htK^h~[5:CJOJQJ^JaJmH sH    6 8 9 ԿԪԕnYG/.h~[hx5:CJOJQJ^JaJmH sH "haaCJOJQJ^JaJmH sH (h~[h~[CJOJQJ^JaJmH sH "h%CJOJQJ^JaJmH sH (h~[h%1CJOJQJ^JaJmH sH (h%h~[CJOJQJ^JaJmH sH (h%hXW:CJOJQJ^JaJmH sH (h%h%CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH +h%h%1CJH*OJQJ^JaJmH sH 9 ; A B I J z { } ӽӽӽӽ}nXE$h=+h%1CJOJQJ^JmH sH *h=h%15>*CJOJQJ^JmH sH h%15CJOJQJmH sH $h h%1CJOJQJ^JmH sH .h~[hx5:CJOJQJ^JaJmH sH (h~[h%1CJOJQJ^JaJmH sH +h qh%15CJOJQJ^JaJmH sH .h qh%15:CJOJQJ^JaJmH sH (h~[5:CJOJQJ^JaJmH sH   4 _ ` ;  @ v1$^vgd}R @ 1$^`gd}R @ ;1$^`;gd}R$ @ 1$^a$gdO$ @ v1$^va$$  1$^`a$gd  ` a : ; = > T V W k ڸo[H5[$hFh%1CJOJQJ^JmH sH $hFh=+CJOJQJ^JmH sH 'hFh%15CJOJQJ^JmH sH 1h=h%15:>*CJOJQJ^JaJmH sH $h=+5:CJOJQJ^JmH sH  h%15:CJOJQJmH sH h%1OJQJh%1h%1CJOJQJmH sH 'h=+h%15CJOJQJ^JmH sH $h=+h%1CJOJQJ^JmH sH $h=+h=+CJOJQJ^JmH sH ; < = T U V   I i    1$^ gdF @ v1$^vgdF @  1$^ gdF @ 1$^`gdF$ @ ;1$^`;a$gd=+$ @ v1$^va$    ; < H I J T U r s )*`a}l hFh=+OJQJ^JmH sH $hFh}RCJOJQJ^JmH sH $htK^h=+CJOJQJ^JmH sH 'hFh%15CJOJQJ^JmH sH hFCJOJQJ^JmH sH $htK^h%1CJOJQJ^JmH sH $hFh=+CJOJQJ^JmH sH $hFh%1CJOJQJ^JmH sH $()`#_acxym$ @ 1$^`a$gdO$ @ 1$^`a$gdF$ @ v1$^va$ @  1$^ gdF$ @  f^ `fa$gdF @ 1$^`gdF @ v1$^vgdF#$%Gbdyz%(?Il ξξΫtatNtNt;$htK^hfCJOJQJ^JmH sH $htK^hPCJOJQJ^JmH sH $htK^hOCJOJQJ^JmH sH $htK^h%1CJOJQJ^JmH sH hOCJOJQJ^JmH sH 'hFh%15CJOJQJ^JmH sH $hFh%1CJOJQJ^JmH ,sH ,hFCJOJQJ^JmH sH $hFh%1CJOJQJ^JmH sH hFOJQJ^JmH sH  hFh%1OJQJ^JmH sH moIm[]<^$ @ 1$^`a$gd=3 @  V1$^ `Vgdf$ @ v1$^v`a$$ @ 1$^`a$gdO$ @ v1$^va$DEZ[\^_ 0ízzgzzgzzTAz$htK^h)ECJOJQJ^JmH sH $htK^h%1CJOJQJ^JmH sH $htK^h%1CJOJQJ^JmH sH $h=3h%1CJOJQJ^JmH sH h^CJOJQJ^JmH sH h=3CJOJQJ^JmH sH *h=h%15>*CJOJQJ^JmH sH -h=h%15:>*CJOJQJ^JmH sH $htK^hCJOJQJ^JmH sH $htK^h^CJOJQJ^JmH sH hi45Ln$ @ 1$^`a$gd)E$ @  f1$^ `fa$$ @ 1$^`a$gd=3$ @ v1$^va$0:ghir{moʷڄmWCCCmC'h=3h%15CJOJQJ^JmH sH *h=h%15>*CJOJQJ^JmH sH -h=h%15:>*CJOJQJ^JmH sH $h)E5:CJOJQJ^JmH sH haaCJOJQJ^JmH sH h)ECJOJQJ^JmH sH $h=3hNfCJOJQJ^JmH sH h%1CJOJQJ^JmH sH $h=3h%1CJOJQJ^JmH sH $h=3hPCJOJQJ^JmH sH 12i?D 5^`5gd'w$ @  f1$^ `fa$ @  f1$^ `fgdcm@$ @ v1$^va$gdm$ @ 1$^`a$gd)E$ @ v1$^va$2;U,hdzyfSf@0@h'wCJOJQJ^JmH sH $h=3h%1CJOJQJ^JmH sH $h'wh%1CJOJQJ^JmH sH $h'wh'wCJOJQJ^JmH sH $htK^h)ECJOJQJ^JmH sH $h=3h%1CJOJQJ^JmH ,sH ,'htK^h'w5CJOJQJ^JmH sH 'htK^h%15CJOJQJ^JmH sH $htK^h%1CJOJQJ^JmH sH $htK^hmCJOJQJ^JmH sH $htK^h'wCJOJQJ^JmH sH h>jBmDʷʤ~~kkkkXkE$htK^hwCJOJQJ^JmH sH $h=3h^GVCJOJQJ^JmH sH $h=3hwCJOJQJ^JmH sH $htK^hwCJOJQJ^JmHsH$htK^h)ECJOJQJ^JmHsH$htK^hfCJOJQJ^JmHsH$htK^h#RCJOJQJ^JmHsH$htK^h%1CJOJQJ^JmHsH$h=3h%1CJOJQJ^JmH sH h#RCJOJQJ^JmH sH /0pBy 1$^`gdk @  f1$^ `fgdcm@ z^`zgd^GV z^`zgd z# z^`zgd^GV 5^`5gd'w-08:GRS\]ͺjU@*@+h'wh'w6CJOJQJ^JaJmH sH (h'wh'wCJOJQJ^JaJmH sH (haah^GVCJOJQJ^JaJmH sH (haah#RCJOJQJ^JaJmH sH (haah'wCJOJQJ^JaJmH sH $haahaaCJOJQJ^JmH sH $haah#RCJOJQJ^JmH sH $haah'wCJOJQJ^JmH sH htK^h'wCJmH sH $htK^hwCJOJQJ^JmH sH $htK^h#RCJOJQJ^JmH sH +op);<=AKkٳp[I4[(htK^h#RCJOJQJ^JaJmH sH "h^GVCJOJQJ^JaJmH sH (htK^h^GVCJOJQJ^JaJmH sH (h'wh'wCJOJQJ^JaJmH sH "h^GVCJOJQJ^JaJmH sH h^GVCJOJQJ^JaJh#RCJOJQJ^JaJ h'wh'wCJOJQJ^JaJ(hI_h#RCJOJQJ^JaJmH sH (h'wh'wCJOJQJ^JaJmH sH "h#RCJOJQJ^JaJmH sH krx9vaL7"(hkhI_CJOJQJ^JaJmH ,sH ,(h z#hI_CJOJQJ^JaJmH sH (h z#hI_CJOJQJ^JaJmH sH (h z#hI_CJOJQJ^JaJmH sH  h z#hI_CJOJQJ^JaJ$haahaaCJOJQJ^JmH sH (h z#hI_CJOJQJ^JaJmH sH "hI_CJOJQJ^JaJmH sH (h:h z#CJOJQJ^JaJmH sH (h:h'wCJOJQJ^JaJmH sH (h:h^GVCJOJQJ^JaJmH sH ʵxfTfT>&.h=h%15>*CJOJQJ^JaJmH sH +hkhcm@5CJOJQJ^JaJmH ,sH ,#hkh85CJOJQJmH ,sH ,#hkh'w5CJOJQJmH ,sH ,(hkh8CJOJQJ^JaJmH sH $hkhkCJOJQJ^JmH ,sH ,(hkhkCJOJQJ^JaJmH sH (hkhkCJOJQJ^JaJmH ,sH ,hkCJOJQJ^JmH ,sH ,$hkh'wCJOJQJ^JmH ,sH ,$hkhwCJOJQJ^JmH ,sH , ( * + { $ @ ;1$^`;a$gdcm@ @ 1$^`gdcm@$ @ 1$^`a$gdcm@$ @ v1$^va$$ @ 1$^a$gdk$ @ 1$^`a$gdk { | ! !Z![!!!!!""-"."p"q""­mmm˜mX(h8h%1CJOJQJ^JaJmH ,sH ,(htK^hcm@CJOJQJ^JaJmH sH +htK^h%15CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH (h#Rhcm@CJOJQJ^JaJmH sH (h8h%1CJOJQJ^JaJmH sH "hcm@CJOJQJ^JaJmH sH +h8h%15CJOJQJ^JaJmH sH  !Y!Z!!!!!","-"p"""U#V#W#X#Y#s# 1$^$a$gdcm@$ @ 1$^`a$gdcm@$ @ v1$^va$ @ ;1$^`;gdcm@ @ 1$^`gdcm@""U#Y#Z#s#t#u#######ɳt_t_J5#"hHCJOJQJ^JaJmH sH (haah%1CJOJQJ^JaJmH sH (haahHCJOJQJ^JaJmH sH (h8h%1CJOJQJ^JaJmH sH "hcm@CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH .htK^h%15>*CJOJQJ^JaJmH sH +hcm@hcm@5CJOJQJ^JaJmH sH (hcm@h%1CJOJQJ^JaJmH sH hcm@h%1OJQJ^JaJ$hcm@hcm@OJQJ^JaJmH ,sH , s#t#####<$=$>$p$$$$$$$ @ vd^va$$ @ 1$^`a$gdH$ @  f1$^ `fa$gdaa$ @ ;1$^`;a$gdH$ @ 1$^`a$gdcm@$ @ v1$^va$#<$>$?$p$q$$$$$$$$$%,%-%.%R%Z%%%%%%%%ٵٵǠٵr\G(h`5:CJOJQJ^JaJmH sH +h8h%15CJOJQJ^JaJmH sH .h=h%15>*CJOJQJ^JaJmH sH +h=h`>*CJOJQJ^JaJmH sH (h8hPCJOJQJ^JaJmH sH "h`CJOJQJ^JaJmH sH "hHCJOJQJ^JaJmH sH (h8h%1CJOJQJ^JaJmH sH "haaCJOJQJ^JaJmH sH $ %R%%%%%%%&&''h(j(n)p)d*f*o+q+ $v1$^va$ $1$^a$gd`$ @ v1$^va$$ @ 1$^`a$gd`$ @  f1$^ `fa$%%%%%%F&}&~&&&-'P'''''Ӿ|gR|?,$h%h%1CJOJQJaJmH sH $h%h%1CJOJQJaJmH ,sH ,(htK^h%1CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH ,sH ,+h%h%16CJOJQJ^JaJmH ,sH ,+h%h%1CJOJQJ\^JaJmH sH +h%h%15CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH (h8h%1CJOJQJ^JaJmH sH .h8h%15:CJOJQJ^JaJmH sH ''''((h(j(((((((H)])p)y))J*տ뫕lWA+h%h%16CJOJQJ^JaJmH ,sH ,(htK^h%1CJOJQJ^JaJmH sH +htK^h%16CJOJQJ^JaJmH sH $h%h%1CJOJQJaJmH sH +h%h%16CJOJQJ^JaJmH sH 'h%h%16CJOJQJaJmH sH +h%h%1CJOJQJ\^JaJmH sH +h%h%15CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH J*K*d*f*o**O+o+q+r+{+,B,a,r,,,,,6-í֗ÃmXC֭(h%h`CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH +h%h%16CJOJQJ^JaJmH ,sH ,'h%h`CJOJQJ\aJmH sH +h%h%16CJOJQJ^JaJmH sH +h%h%1CJOJQJ\^JaJmH sH $h%h%1CJOJQJaJmH sH (h%h%1CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH ,sH ,q+,,--..//0011o2p2Y3Z3444656$ @ vd1$^va$gdP$ @ vd1$^va$$v1$^v`a$$ @ d1$^`a$gd`6-----...../////o0ңv`J5v(htK^h%1CJOJQJ^JaJmHsH+htK^h%1CJOJQJ\^JaJmHsH+htK^h`CJOJQJ\^JaJmH sH (h%h%1CJOJQJ^JaJmH sH /htK^h%1CJEHOJQJ\^JaJmHsH,htK^h%1CJEHOJQJ^JaJmHsH/h%h%1CJEHOJQJ\^JaJmH sH ,h%h`CJEHOJQJ^JaJmH sH ,h%h%1CJEHOJQJ^JaJmH sH o000000000D1111111p^pM;)#h%h%1CJOJQJ\^JaJ#h%h`CJOJQJ\^JaJ h%h%1CJOJQJ^JaJ"h^GVCJOJQJ^JaJmH ,sH ,(h%h%1CJOJQJ^JaJmH ,sH ,+h%h%1CJOJQJ\^JaJmH sH $h%h`CJOJQJ^JmH sH $h%h%1CJOJQJ^JmH sH (h%h%1CJOJQJ^JaJmH sH (htK^h^GVCJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH 1Y2Z2b2c2i2p2q2}222338393X3Z3iWB(h%hPCJOJQJ^JaJmH sH "h^GVCJOJQJ^JaJmH sH +h%h%1CJH*OJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH #h%h%1CJOJQJ\^JaJ h%h`CJOJQJ^JaJh^GVCJOJQJ^JaJ(h%h^GVCJOJQJ^JaJmH sH (h^GVh^GVCJOJQJ^JaJmH sH  h%h%1CJOJQJ^JaJZ3[3d34444445555565666v666ӾӾnYHn6n#h%h%1CJOJQJ\^JaJ h%h`CJOJQJ^JaJ(htK^h%1CJOJQJ^JaJmH sH h%h%1CJOJQJ^JaJ& jh%h%1CJOJQJ^JaJ(h%h`CJOJQJ^JaJmH sH +h%h%1CJH*OJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH +h%h%1CJOJQJ\^JaJmH sH +h%h`CJOJQJ\^JaJmH sH 5677c9d9::;;<<==>>??@@AABB $^a$gd`$ @ vd1$^va$$ @ d1$^`a$gd`67777788969d9e9r9{9!:#:::::7;9;;;;;<<<<B=p===3>ŰoZZZo(h%h`CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH +h%h%1CJH*OJQJ^JaJmH sH +h%h%1CJOJQJ\^JaJmH sH (h%h%1CJOJQJ^JaJmH sH (htK^h`CJOJQJ^JaJmH sH h%h%1CJOJQJ^JaJ(h%h%1CJOJQJ^JaJmH ,sH ,"3>7>>>>>>?V?X??????T@V@@@@@dAfAAAAABBnCخؘ؂oؘ؂خؘ؂خؘZ(htK^h`CJOJQJ^JaJmH sH $h%h`CJOJQJ^JmH sH +h%h%1CJH*OJQJ^JaJmH sH +h%h%1CJOJQJ\^JaJmH sH (h%h`CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH $h%h%1CJOJQJ^JmH sH BCCDD FFGG H H I!IhJiJZK[KLLMM6O7O+P,P$ @ vd1$^va$$ @ d1$^`a$gd`nCCCDDEEFFFFFGGGG HHHH!I#IhJiJkJ[K]KLLMMlYl$h%h`CJOJQJ^JmH sH $h%h%1CJOJQJ^JmH sH . jh%h%1CJOJQJ^JaJmH sH (htK^h`CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH (h%h`CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH MMO7O9OOO,P.PQQRR SSSS>T@TUUU&W9WîllllllWE"h^GVCJOJQJ^JaJmH sH (h%h%CJOJQJ^JaJmH sH (h%h`CJOJQJ^JaJmH sH .h%h%16CJOJQJ]^JaJmH sH (h%h%1CJOJQJ^JaJmH sH (htK^h`CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH $h%h`CJOJQJ^JmH sH ,PQQRRSS=T>TUUaWbWXXZZb[c[ @ vd1$^v @ d1$^`gd` @ d1$^$ @ vd1$^va$$ @ d1$^`a$gd`9W:WCWbWdWXXYYYYYZZZZ1[Dzǝss]J5(h%h%1CJOJQJ^JaJmH sH $h%h`CJOJQJ^JmH sH +h%h%15CJ OJQJ^JaJ mH sH (h%heCJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH (h%h`CJOJQJ^JaJmH sH (h%h`CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH "h^GVCJOJQJ^JaJmH sH "heCJOJQJ^JaJmH sH 1[H[O[b[c[e[h[\]]]^^p`q```rasaðr]]K]8$h%hCJOJQJ^JmH sH "heCJOJQJ^JaJmH sH (h%h`CJOJQJ^JaJmH sH +h%h%15CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH $htK^h tCJOJQJ^JmH sH $htK^h`CJOJQJ^JmH sH $htK^h%1CJOJQJ^JmH sH (htK^heCJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH c[f[]]^^``rasaccdn @ d1$^`gd` @ d1$^gd  @  d1$^` gd`$ @ vd1$^va$$ @ d1$^`a$gd` @ vd1$^v @ d1$^`gd` satabbccmdndodzdddeeeeeeffggg gg1gرررr`rK`r(h%heCJOJQJ^JaJmH ,sH ,"heCJOJQJ^JaJmH ,sH ,(h%hg FCJOJQJ^JaJmH ,sH ,(h%hg FCJOJQJ^JaJmH sH (h%hg FCJOJQJ^JaJmH sH (h%h`CJOJQJ^JaJmH sH "heCJOJQJ^JaJmH sH (h%h CJOJQJ^JaJmH sH $h%h`CJOJQJ^JmH sH ddee2g3ghhjjl$ @ d1$^`a$gdEc$ @ d1$^`a$gdEc$ @ vd1$^va$$ @ d1$^`a$gd`$ @ d1$a$gd  @  d1$^` gd` @ d1$^gd 1g2g3g4ghhhhhh*ijj jlWB,+h%hV4\CJH*OJQJ^JaJmH sH (h%hV4\CJOJQJ^JaJmH ,sH ,(h%h`CJOJQJ^JaJmH ,sH ,(h%h%1CJOJQJ^JaJmH sH (h%hV4\CJOJQJ^JaJmH sH +h%hM?ЖіҖӖKL֩}fQ8Q8Q8Q1jh}bhE6CJOJQJU^JaJmH sH (h}bhE6CJOJQJ^JaJmH sH ,h}bhE60JCJOJQJ^JaJmH sH (h}bh%2CJOJQJ^JaJmH sH ,h}bh|0JCJOJQJ^JaJmH sH /h}bh|0J6CJOJQJ^JaJmH sH )jh}bh|CJOJQJU^JaJ(h}bh|CJOJQJ^JaJmH sH (h}bhuzCJOJQJ^JaJmH sH !jkdeNOQe#$]ԿnUnUnUn@nUn(h}bhEy9CJOJQJ^JaJmH sH 1jh}bhw\CJOJQJU^JaJmH sH (h}bhw\CJOJQJ^JaJmH sH  h}bhw\CJOJQJ^JaJ#h}bhw\6CJOJQJ^JaJ1jh}bhtK^CJOJQJU^JaJmH sH (h}bhtK^CJOJQJ^JaJmH sH (h}bhE6CJOJQJ^JaJmH sH +h}bhE66CJOJQJ^JaJmH sH ]^ϜFG<=>JdߟѻѩnYnYnYCY+h}bh>w6CJOJQJ^JaJmH sH (h}bh>wCJOJQJ^JaJmH sH 1jh}bh>wCJOJQJU^JaJmH sH  h}bh>wCJOJQJ^JaJ h}bhw\CJOJQJ^JaJ#h}bhw\6CJOJQJ^JaJ+h}bhw\6CJOJQJ^JaJmH sH (h}bhw\CJOJQJ^JaJmH sH 1jh}bhw\CJOJQJU^JaJmH sH ߟgpޡߡ01\cpqr뾡뾡|k]HkH)jh$FhSK0JCJUaJmH sH hSK0JCJaJmH ,sH , h$FhSK0JCJaJmH ,sH ,hCJOJQJ^JaJ,h}bh0JCJOJQJ^JaJmH sH 8h}bh0J>*B*CJOJQJ^JaJmH phsH )jh}bhCJOJQJU^JaJ.h}bh5CJOJQJ\^JaJmH sH (h}bhCJOJQJ^JaJmH sH 23\rݥޥ -DM gdK-DM ^gdK--DM `-gdSK-DM ^gdSK -DM gdSKgd}b=>?ܥޥ#$]^ϦЦѦ%&'`a§ç˨̨ͨWXYbcrs̻ڻﭟ hGkhK0JCJaJmH sH hK0JCJaJmH sH h}bCJOJQJ^JaJ hSKhSK0JCJaJmH ,sH ,hSK0JCJaJmH sH )jh$FhSK0JCJUaJmH sH  h$FhSK0JCJaJmH sH 5stPQRFGH68˱kR<*hKCJOJQJ^JaJmH ,nH ,sH ,tH ,0hGkhKCJOJQJ^JaJmH ,nH ,sH ,tH ,,hGkhKCJOJQJ^JmH ,nH ,sH ,tH ,*hKCJOJQJ^JaJmH nH ,sH tH ,0hGkhKCJOJQJ^JaJmH nH ,sH tH ,3hGkhKCJOJQJ\^JaJmH nH ,sH tH ,hK0JCJaJmH sH  hGkhK0JCJaJmH sH )jhGkhK0JCJUaJmH sH 7834 ؽٽ -DM gdn-DM ^gdngdK -DM gdK8IJ4ưǰ߰ST^سٳڳƴɻɻɻɪzzizW#h0]ahK0J6CJaJmH sH  hQChK0JCJaJmH sH )jhQChK0JCJUaJmH sH hK0JmH ,sH , hQChK0JCJaJmH ,sH , hKhK0JCJaJmH ,sH ,hK0JCJaJmH sH  hGkhK0JCJaJmH sH )jhGkhK0JCJUaJmH sH  hduhK0JCJaJmH ,sH ,ƴ(*+de ȸɸFGHPג}}}kZI hml6hK0JCJaJmH ,sH , hKhK0JCJaJmH ,sH ,#hKhK0J6CJaJmH ,sH ,)jhhK0JCJUaJmH sH  hhK0JCJaJmH sH h0]ahK0JmH sH #h0]ahK0J6CJaJmH sH )jhQChK0JCJUaJmH ,sH ,hK0JCJaJmH sH hK0JmH sH  h0]ahK0JCJaJmH sH jyKLƻǻȻػ߼~̷xgUggF;FxFhNyhn0JCJjhNyhn0JCJU#hnhn0J6CJaJmH sH  hnhn0JCJaJmH sH hNyhn0JCJ hNyhn0JCJaJmH sH )jhNyhn0JCJUaJmH sH hn0JCJaJmH sH (h}bh}bCJOJQJ^JaJmH sH  hehK0JCJaJmH sH #hehK0J6CJaJmH sH  hKhK0JCJaJmH ,sH ,ؽٽ?AB{|޾߾`awffR?/?h@sCJaJmH nH ,sH tH ,$h@sh@sCJaJmH nH ,sH tH ,'h@sh@s6CJaJmH nH ,sH tH , hNyhNy0JCJaJmH sH  hNyhNy0JCJaJmH sH )jhNyhNy0JCJUaJmH sH h@sCJaJmH ,nH ,sH ,tH ,$h@sh@sCJaJmH ,nH ,sH ,tH ,'hNyh@sCJ\aJmH ,nH ,sH ,tH ,h@s0JCJaJmH sH hn0JCJaJmH sH hn0J6CJaJmH sH ٽS01p2ld-DM [$\$gd!rn-DM ^`ngd!r-DM ^gd!r -DM gd!r -DM gdNy -DM gdNy-DM ^gdNy -DM gdngd@s dd[$\$gd@s ()*cd IJ/012klᬞxxxn\x#h+h!r0J6CJaJmH sH h!r0JmH sH  h+h!r0JCJaJmH sH )jh+h!r0JCJUaJmH sH h!r0JCJaJmH sH h0JCJaJmH sH #h{QhNy0J6CJaJmH sH )jh{QhNy0JCJUaJmH sH  h{QhNy0JCJaJmH sH hNy0JCJaJmH sH $'(nop34mn ȺjWI<h=h%1OJQJ^Jh%hkQ>*OJQJ^J$huzh%1CJOJQJ^JmH sH (h>whtK^CJOJQJ^JaJmH sH (hh!rCJOJQJ^JaJmH sH  h+h!r0JmH nHsH tH)jh+h!r0JUmH nHsH tHh!r0JmH nHsH tH h!rh!r0JmH ,nHsH ,tH h+h!r0JCJaJmH sH )jh+h!r0JCJUaJmH sH 23 4uk $ 1$a$ ^`gdkQ$ 1$^`a$gdkQ ^`gdkQ$v1$^v`a$$ v1$^va$ -DM gdNyd-DM [$\$gd!rd-DM [$\$^gd!r ?STp_K_6(h%h%1CJOJQJ^JaJmH sH & jh%h%1CJOJQJ^JaJ h%h%1CJOJQJ^JaJ h%hkQCJOJQJ^JaJ(htK^h%1CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH ,sH ,(h%h%1CJOJQJ^JaJmH sH +h%h%1CJOJQJ\^JaJmH sH 'h%hkQCJOJQJ\^JmH sH *h%h%15>*CJOJQJ^JmH sH  56DMj{=ӾiT?T(h%hkQCJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH +h%h%1CJOJQJ\^JaJmH ,sH ,(h%hkQCJOJQJ^JaJmH ,sH ,(htK^h%1CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH ,sH ,(h%h%1CJOJQJ^JaJmH sH +h%h%1CJOJQJ\^JaJmH sH +h%hkQCJOJQJ\^JaJmH sH 45GHIKrst|$ 1$^a$gdYe$ 1$^a$gdYe $^gd $^gd $gd$ v1$^va$$ 1$^`a$gdkQ$ v1$^va$=>GHIJLrt}~ǽiSI6#$htK^hkQCJOJQJ^JmH sH $htK^h%1CJOJQJ^JmH sH hYeCJmH sH *htK^hYe5>*CJOJQJ^JmH sH *htK^h%15>*CJOJQJ^JmH sH 'htK^hr5CJOJQJ^JmH sH 'htK^hkQ5CJOJQJ^JmH sH *hh5>*CJOJQJ^JmH sH hCJmH sH hCJaJmH sH (h%h%1CJOJQJ^JaJmH sH . jh%h%1CJOJQJ^JaJmH sH  |}~"#%&($ 1$^`a$gdZz<$ 1$^`a$gdkQ$ v1$^va$$ 1$^a$gdYe#$&')JKST45QR[acei֭փqq"h#CJOJQJ^JaJmH sH . jh%h%1CJOJQJ^JaJmH sH "hrCJOJQJ^JaJmH sH & jh%h%1CJOJQJ^JaJ(h%hkQCJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH )(JRS34PQbc|}=> 1$^`gdkQ$ v1$^va$$ 1$^`a$gd# ^`gdkQ$ v1$^va$$ 1$^`a$gdkQiqz{|}>@(*įąp[I7"huMCJOJQJ^JaJmH sH "huMCJOJQJ^JaJmH sH (h%hjCJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH (h%hkQCJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH (h#h%1CJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH "h#CJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH  >PRT}$ 1$^`a$gdj$ 1$^a$gdo`v^v^gdj$ 1$^`a$gdj$ ;1$^`;a$gdj$ v1$^va$$ 1$^`a$gdkQ*5PTV|p^II4I(htK^ho`CJOJQJ^JaJmH sH (h%ho`CJOJQJ^JaJmH sH "hrCJOJQJ^JaJmH sH (htK^h%1CJOJQJ^JaJmH sH (h%hjCJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH "huMCJOJQJ^JaJmH sH (h%hjCJOJQJ^JaJmH sH (h%h%1CJOJQJ^JaJmH sH (huMhuMCJOJQJ^JaJmH sH $)2<J39:CHRWbjp"-mXmC(h1Fh#CJOJQJ^JaJmH sH (h1Fho`CJOJQJ^JaJmH sH (h1Fh"lCJOJQJ^JaJmH sH (h#h~CJOJQJ^JaJmH sH (h#ho`CJOJQJ^JaJmH sH (htK^h~CJOJQJ^JaJmH sH (htK^ho`CJOJQJ^JaJmH sH (h%ho`CJOJQJ^JaJmH sH (h%h~CJOJQJ^JaJmH sH ef012 $ 1$a$gd(u$ 1$^a$gd1F$ 1$^a$gdj$ 1$^a$gdo`$ 1$^`a$gdj-.?IJKx 4=묚sasasasO:O(h:h:CJOJQJ^JaJmH sH "h:CJOJQJ^JaJmH sH "hzCJOJQJ^JaJmH sH "h#CJOJQJ^JaJmH sH (h%h1FCJOJQJ^JaJmH sH "h1FCJOJQJ^JaJmH sH (h1Fh1FCJOJQJ^JaJmH sH (h1Fh#CJOJQJ^JaJmH sH (h1Fh"lCJOJQJ^JaJmH sH (h1Fho`CJOJQJ^JaJmH sH =df/02V=ٟzzxzcNFBFBFhvBjhvBU(hDh;CJOJQJ^JaJmH ,sH ,(hDh:CJOJQJ^JaJmH ,sH ,Uhml6hDCJ\aJmH ,sH ,(hDhDCJOJQJ^JaJmH ,sH ,"hDCJOJQJ^JaJmH sH "h!CJOJQJ^JaJmH sH +h!h:6CJOJQJ^JaJmH sH "h:CJOJQJ^JaJmH sH (h:h:CJOJQJ^JaJmH sH 2&P$ 1$^a$gdD$ $1$^a$gdDmulticntrico, doble ciego, aleatorizado, de fase 3 para comparar la eficacia y la seguridad de CXA201 intravenoso con las de meropenem en infecciones intraabdominales complicadas patrocinado por CUBIST, Hospital Bernardo Houssay, 2013     (hDh;CJOJQJ^JaJmH ,sH ,h/&wjh/&wUjhvBUhvBE 000hP:p)E. A!"n#$% Dp^$ 02 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH ,nH ,sH ,tH ,8`8 Normal_HmH sH tH Z@Z Ttulo 1$$ 1$@&a$5>*CJmH sH uX@X Ttulo 2$$ 1$@&a$CJ$OJQJmH sH d@d Ttulo 3!$$ @ v1$@&^va$6CJOJQJmH sH NA`N Fuente de prrafo predeter.ViV 0 Tabla normal :V 44 la ,k , 0 Sin lista N @N  Pie de pgina  C" OJQJkHpC@p Sangra de texto normal$ v1$^va$ CJmH sH XP@X Texto independiente 2$a$ CJmH sH R@" Sangra 2 de t. independiente#$ @  S1$^ `Sa$ CJmH sH ~S@2~ Sangra 3 de t. independiente  c1$^ `c CJmH sH .OA. %2 journalname8R8 |title1CJaJmH sH FObF | rprtbody1 ""CJaJmH sH BrB |aux1d@d\$CJaJmH sH *O* |src1 < O |jrnl:U@: w\0 Hipervnculo >*ph66 w\rprtid1<phiii66 w\ rprtlinks1 <<< w\ status_icon1 5\phW5R^R 1F Normal (Web)dd[$\$CJaJmH sH BOB descdd[$\$CJaJmH sH HH details dd[$\$CJaJmH sH  }bhpsB!B }bapple-converted-spaceH2H @stitle#dd[$\$CJaJmH ,sH ,tH ,PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!&lTRtheme/theme/theme1.xmlYMoE#F{oc'vGuرHF[xw;jf7q7J\ʯ AxgfwIFPA}H1^3tH6r=2%@3'M 5BNe tYI?C K/^|Kx=#bjmo>]F,"BFVzn^3`ե̳_wr%:ϻ[k.eNVi2],S_sjcs7f W+Ն7`g ȘJj|l(KD-ʵ dXiJ؇kZov[fDNc@M!͐,a'4Y_wp >*D8i&X\,Wxҕ=6.^ۄ Z *lJ~auԙՍj9 !bM@-U8kp0vbp!971 bn w*byx$پ,@\7R(=Q,)'KQk5qpq Qz,!_ Y4[an}`B-,#U,ђMpE`35XYd״?%1U9إ;R>QD DcNU'&LGpm^9+ugVh^n<*u7ƝSdJ9gn V.rF^*Ѕ҈}-p !:P5gyڧ!# B-;Y=ۻ,K12URWV9$l{=An;sVAP9zszH'[`ۇ@PbW<{ˆ1W+m_SsncY̕([ @}`g >V?4hf6՗t#M&ʺ6'B gks:\qN-^3;k ] =Y42&0GN|tI&MI`=DCPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!&lTRtheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] @  w 9 0hk"#%'J*6-o01Z363>nCM9W1[sa1g jluoOq$|L']o0N]ߟs8ƴ =i*-=y{}z ; m s#$q+56B,Pc[djs#~M2ٽ24|(>2z|~.]!>KjdN#]F<ޙ0p=#]Ϟ&`̠WbsPGIS٫*dȰFKƳ~A{޶)cIԺ1k'n3m@XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX8;A@@V( n \B  S Do"?VB   C D"?\B  S Do"?B S  ?z@SwwtSt C%t OLE_LINK1 _Hlt234911703 _Hlt234911704 _Hlt234911705 _Hlt234911734 _Hlt234911735 _Hlt234911659 _Hlt234911660 _Hlt234911661 _Hlt234911676 _Hlt234911677 _Hlt234911770 _Hlt234911771 _Hlt234914616 _Hlt234914617 _Hlt234914636 _Hlt234914637 _Toc428503041 _Toc428503226 _Toc431345658 _Toc428503042 _Toc428503227 _Toc428503043 _Toc428503228 _Toc431345659 _Toc431345660TiiiJA@@@@@@@@ @ @ @ @ @@@@TJAllhl,hl,hllhlhllhlhlhllhlhl,hl,hl,hlhllhllhl,hllhllhlhl,hlhlhllhlhl,hlhl,hlhl,hlhllhlhlhlhlhllhlhl,hllhllhlhlhl&glmėG?mG@mDGAmęGBmĘGCmGDmDGEmDGFmDGGmDGHmĎGImGJmGKmGLmDGMmGNmDGOmGPmĒGQmďGRmđGSmĐGTmGUmGVmGWmGXmēGYmDGZmG[mČG\mDG]mG^mDG_mčG`mԣGamTGbmGcmTGdmGemGfmTGgmGhmGimGjmGkmԠGlmԜGmmGnmԡGomGpmԟGqmTGrmԝGsmԢGtmGumGvmGwmGxmGymGzmG{mG|mG}mTG~mGmGmԥGmGmGmԫGmTGmGmԧGmԩGmTGmԤGmTGmGmGmGmGmGmGmGmԲGmTGmGmTGmGmTGmGmTGmGmGmGmGmԹGmTGmTGmGmԵGmGmԺGmTGmGmԻGmԷGmGmTGmGmGmԴGmGmԸG""0aao*WGGUz33C\\eii | |   * xAAO~~aG G P W M!V!V!]!T"""O#O#X#\#^%&&&&y'y''((++I,e,e,j,11-111A122S2S2a2l2i3i3w33W4g4g4u4[5[5h5p56666777788889999:::==BFBFGG?S?STT4XZ9\]^^```aaaAbbcLdDeGesfvf^g^ggg#FXxЄ[8|77wwRR A      !"#$%&'()*+,-./0123465798:;<=>?@ABCDFEGIHJLKMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy|z{}~.99mxx(33b''S^^;;Scggll ( 3 3 ''MXXvN U U f P![![!l!b"""V#Z#Z#m#q%&&&&'''(( + +P,h,h,~,+1/14141Q122_2j2j2}2u3333e4s4~4~4f5n5n5}56666777788889999:::==KFKF$G$GBSBSTTIXZN\]^^```aa bKbccfdYeiefftgwggg!1Ve߄qG >>[[ A   !"#$%&'()*+,-./0123465798:;<=>?@ABCDFEGIHJLKMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy{|z}~ =*urn:schemas-microsoft-com:office:smarttags PlaceName=*urn:schemas-microsoft-com:office:smarttags PlaceType9*urn:schemas-microsoft-com:office:smarttagsState8*urn:schemas-microsoft-com:office:smarttagsdate8*urn:schemas-microsoft-com:office:smarttagsCityB*urn:schemas-microsoft-com:office:smarttagscountry-region9*urn:schemas-microsoft-com:office:smarttagsplace>*urn:schemas-microsoft-com:office:smarttags PersonNameC*urn:schemas-microsoft-com:office:smarttagsmetricconverter rF7110111219611987199019921993199419951996199822 in20002001200821222630456789 Carlos LunaDaniel LopardoDayDiana Christensenem pacientes com SIDA.em pacientes com SIDA. IXFUNCEI, FundacinGuillermo BenchetritGustavo LopardoJ. 2009Jorge Martinez Jos Gonzalezla Asociacin Panamericanala comunidad. Medicinala comunidad. VII Congresola InvestigacinLa Sagrada Familia la Sociedadla Sociedad ArgentinaLautaro De VediaLucia MarzorattiMonth Paula Peyrani ProductID Ramirez J.Year10 0w\0@a!Ja P00 0w\0*Ja P00 0w\0ߺJa P00 0w\0Ja P00 0w\0ߺJa P00 0w\0Ja P00 0w\0Ka P00 0w\0Ka P00 0w\0hKa P00 0w\0pKa P00 0w\0Ka P00 0w\0XKa P00 0w\0Ka P00 0w\00Ka P00 0w\0Ka P00 0w\0 Ka P00 0w\0(Ka P00 0w\0PKa P00 0w\0Ka P00 0w\0Ka P00 0w\0uKa P00 0w\0@~Ka P00 0w\0ںgKa P00 0w\0PKa P00 0w\0պYKa P00 0w\0޺BKa P00 0w\0ںKKa P00 0w\0X׺4Ka P00 0w\0պ=Ka P00 0w\0@ֺ&Ka P00 0w\0Ժ/Ka P00 0w\0޺Ka P00 0w\0ֺKa P00 0w\00׺ Ka P00 0w\0׺4a P00 0w\0غ4a P00 0w\0Pں4a P00 0w\0ۺ4a P00 0w\0ܺ4a P00 0w\0ܺ4a P00 0w\0Pߺ4a P00 0w\0ߺ4a P00 0w\04a P00 0w\0x4a P00 0w\04a P00 0w\084a P00 0w\04a P00 0w\04a P00 0w\0xq4a P00 0w\0z4a P00 0w\0@c4a P00 0w\0l4a P00 0w\0U4a P00 0w\00^4a P00 0w\0G4a P00 0w\004a P00 0w\0 94a P00 0w\0p"4a P00 0w\0+4a P00 0w\084a P00 0w\04a P00 0w\04a P00 0w\0x4a P00 0w\05a P00 0w\0@5a P00 0w\05a P00 0w\05a P00 0w\0X5a P00 0w\05a P00 0w\05a P00 0w\0p5a P00 0w\05a P00 0w\085a P00 0w\05a P00 0w\05a P00 0w\0(5a P00 0w\0x5a P00 0w\0v5a P00 0w\0@5a P00 0w\0h5a P00 0w\0Q5a P00 0w\00Z5a P00 0w\0C5a P00 0w\0L5a P00 0w\0H55a P00 0w\0>5a P00 0w\0'5a P00 0w\0`5a P00 0w\05a P00 0w\05a P00 0w\0x 5a P00 0w\06a P00 0w\06a P00 0w\06a P00 0w\06a P00 0w\0X6a P00 0w\06a P00 0w\0 6a P00 0w\0p6a P00 0w\06a P00 0w\086a P00 0w\06a P00 0w\0(6a P00 0w\0x6a P00 0w\06a P00 0w\0@r6a P00 0w\0{6a P00 0w\00d6a P00 0w\0m6a P00 0w\0V6a P00 0w\0H_6a P00 0w\0h= 5 2)@We8YW8cXe XHXp+YY(ZxZZ@[[\X\\\p]]`^^(___h``0aaabccdxdhefP]*@We8YW8cXe XHXp+YY(ZxZZ@[[\X\\\p]]`^^(___h``0aaabccdxdhefXfeF JPO :i+00/F:\20:- CVINGL~1.DOCh::cv ingles junio 2009 gustavo lopardo.doc@ PO :i+00/F:\20:- CVINGL~1.DOCh::cv ingles junio 2009 gustavo lopardo.doc? ,Espaol (Argentina)kt@@kt Ingls (Estados Unidos)ktH@@ktD Espaol - Espaa (alfabetizacin tradicional)kt@@kt0B Espaol (alfabetizacin internacional)ktp@@kt%  1=M".6U:LL}Rp|Fbjx;kAWI}W =E*<>mB|xZTuZjr-3YoGu-955,]2JFeJxt \brz %iKQwgh=5Lopardo G, Guzzi L, Niccodemi MC, Espinola L, Lijavetzky A, Poggi E, Barcelona L, Benchetrit G, Gonzlez J, Videla A, Rodrguez M, Christensen D, Peyrani P, Ramrez J y grupo CAPO. Mayor frecuencia de bacteriemia en pacientes con neumona en Argentina en relacin con otras reas del mundo. VIII Congreso de la Sociedad Argentina de Infectologa. Mar del Plata. May 22-24,2008. Oral sessionl. Abstract 22899 887  i˅M w-ww,wP9::<99`:swvHwHwww\wqKwdxwvwvwvwP9::9<9RKw9PwJwIw`wwwwGwϿww-KwNw~wwNwKw'wwwwwwwwww@w@w@w@w@w@w@w@w@w@w@w>ZVx3l P!p3l&p3l "p3l  XHH P!p3l H   HP!p3l Hp3l H p 3l HHp 3l   H P!H&p3lH Fp 3l Hp=fpF RBxq #J|  ._3151 5151 5151515153-3,153.15151515 15 15 15 15 1  515151515151515153*3.3.3.3.3.1515343(34363.3.3 3!3.333&303'3/3#3$323)3%323$3"3+3ir pwx~%-? G p u y   R Z _ g M T U ] *0;I(-jBmw'X\inr{39#-  XfHR #$,-=oxyqvOTLTbo-01;<Cj r !!!!"!&!.!/!6!!!|""####$$$$% %9%A%B%K%%%%%%%%%%%%%& &Z&d&&&&&'*'/';'<'C'D'O''''''(( (((((()(4([(c(q(y((((((() )))))*********+0+f+m+q+w+{++++++++++++,,,,,,,,,,e-t-..%.-.6.=.K.S.W.].a.i.....//////////0011}1111111122222222223333334!4444444444444555555555556666!66666666666777777%8.8/888888888888888-9899999:::::::::::::::;;;;;;";&;1;4;O;;;;;;;<<<<==*=4=B=H=t=}=========>>(>2>K>T>Y>`>e>k>>>>>>>>>>>>>>?!?(?,?3?7?@?@#@=@F@U@\@`@g@ AA.A5A:AAAFAOABBkBsBBBBBCCmCuCCCCC>DFDDDDDDDEEEEEEEEEEEEEEEEEFF FFFFFFFFF9G>GBGKGOGUGGGGGGHFHPHlHrHwHH%I-IlItIIIIIIIBJJJJJJJKKNKVKKKKKKLULLLMMMM&N0NOOOOOOOOOO`PePvP~PPPPPPPQRRRRR R&R+R5R:R@RWR]RaRiRRR"S/ShSqSSSSSSSSSSS$T,TTUU UUU.U3U7U@UQUYU]UgUUUUUVVVVVVVVWWCWJWNWYW]WdWkWrW}XXXXXXXXXXcYkYYYYYYYYYYYYYYZZZZZZ[[[*[4[8[=[A[F[N[V[[[[[\\\\\\\\\\\\\\]]]]]]]]^^)^0^4^:^>^G^K^T^X^`^d^l^p^z^~^^^___ _(_C_H_L_R_a_h_l_u_y________` `m`z```````aaaaSa[abagahapaaa b%b6b=bpb{b0c6c8c=c`cecicrcwc~cccccccccccccccccccd d dddddd d-d.d4d5d:dddddddddeeeeeeeeeeeeeeXfbffffuggggggh hhhiiii'ijj'j0j5j;j^jhjyjjjjkkk%k*k1ksk}kll/l5l:lAlFlMlilslllm$m-m9m=mDmHmMmQmZm^mhmlmumymmmmGnOnXnanenjnxn~nnnnnnnnnnnno|ooooooooZpbpvp{pppppppppppqqqqqqqqqqqqqqqqqrrs sss!st tt t%t/t3tvbvmvvvvvvviwpwtw|wwwxxxxxxxxxxxxxxxxyyyyyyz zzzz"z.z9zz{b{{{ | |)|*|s|u|}}}}}}}}~(~4~;~@~K~P~U~\~`~h~l~r~v~~~~~~~  !*LRV^u{BI[e~րހƁЁ߁ ,5]f &6;X_lqu} )1LV]eąхڅ† +/HNRZ_eios{")6<@GKQU^ NT؋#):?DL%)OWelpuӎ؎ LScimt")lo‘ʑΑՑّߑ!%-19=DHO\aAJ]esxʓϓԓړޓ ” >DfkpvBMNUΗӗߗ"&.29=DHLPZ^ejos{͘Ә ,59AEJNVZcrw{ty}CHINOVŜʜ˝ϝ n&.HQU\`hltx}ȠYaXdpvˢ DJRVnqĤȤҤ֤ޤ %)-2:>C.58=ADHOTZ^eir¦Ǧ˦Ӧצ %&+<ABG "&=GUZ^chn%.7~۩%/cf|ʪҪ֪ܪ",xt!&  /7;@ԯׯ8>CHMT"HLMPknñ˱۱uyIJʲ27IT_dhsƵѵ(,2>Bbh޷$ָ۸ahlot{ֺں*#.27;BFM^bڼ޼{ýȽͽֽڽ˾̾߾-8<BRYrzտؿx{6@O[msGJ&z8?FKMVcghpqyUaphu$,s %6?!/fk /43=HST_#5L$6J!-5ISX`#.@KAL\e=IMPQVx  4@MX$0478=>KZf-.0134679:>A;i a"$Fz/0[p% ' o H Z ,: jCEO+-,z| >.M qx E F #!H!K!"""N#r$$$5%s%%f&&&&&&&&a'b'x'''''n(o((((***++1+2+F+G+X+,i,,,--01S1b1 2k2633 4V45A5X66Q77O8888_9999R::==FGQQRRR0SUSaS*U-U^^3``bapaaaaaAbHbf/fffggggsss!tttz{b{(|*|}}}~ 364;&-@G  -A333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333";;$z\pr ,q? !f"+*q*2233W44p5566<<EEEvPPQRTU]]^4_``abzeeffggj!jjkllm+m-{W{}}(~K~2W=#lg>e—?X˝ўßޟc84eHj׵ֺ/^Lu,T"eq{.0134679:>AKLƳdzߴ|޶߶XX`apɽɽ>-..11A |:&}~HDtxf7:E p.8א 4%^`.^`.^`.^`. ^`OJQJo( ^`OJQJo( ^`OJQJo( ^`OJQJo(hh^h`. hh^h`OJQJo( ~}| Kw(uRu4q!Ze Za!@ U@e xh6H (L!6p*$> KF@ xhI)PlK"2"bW<dkq0FL|0@h"bW{Y8slkk28 xh,B &R% 5+8_Za!28 xh"^"|T YwYwYwYwh"$1I#@ $eth'Kl<!( KFP(T#J ZZZ:sK,!6w},:sK, xhk!.`?.K|J&D.uRV97&R%28hx^PKlOG T Y o:}R^DCj:cV^#%)EAP# z#$& +=+@-%1 2=3f3E6Ey92J:XW:Zz<F}>cm@TSA6LBg F1FwCF^1GSK4~NX PPkQMwxzuzn~!!r0#R'u%28ez |^_Wk~)(u~[';F6fQB='ws9wK2nNyM|b tmw$0:w\Ea1 HjlFuM#vBHcr%=o`(||`.0@4>@X@XX@X@UnknownG.Cx Times New Roman5Symbol3. .Cx Arial3.Cx TimesI. ??Arial Unicode MSY New YorkTimes New RomanO1 CourierCourier NewA$BCambria Math"1%\E'g F#vv#vv!4d 2qHX $PP2!xxCURRICULUM VITAEGustavo LopardoGustavo4         Oh+'0  0 < H T`hpxCURRICULUM VITAEGustavo LopardoNormalGustavo13Microsoft Office Word@$e @0/'@,nv@#v՜.+,D՜.+,H hp  UTHSC-Houstonv CURRICULUM VITAE Ttulo, 8@ _PID_HLINKSA!6`,http://www.ncbi.nlm.nih.gov/pubmed/26192873 +0],http://www.ncbi.nlm.nih.gov/pubmed/26339883 &4Z,http://www.ncbi.nlm.nih.gov/pubmed/26424460 %>W,http://www.ncbi.nlm.nih.gov/pubmed/25826420 !5T,http://www.ncbi.nlm.nih.gov/pubmed/25711317 !;Q,http://www.ncbi.nlm.nih.gov/pubmed/25179510 "5N,http://www.ncbi.nlm.nih.gov/pubmed/25004134 ,9K,http://www.ncbi.nlm.nih.gov/pubmed/24870935  ;H,http://www.ncbi.nlm.nih.gov/pubmed/24626096 %0E,http://www.ncbi.nlm.nih.gov/pubmed/24356278 %1B,http://www.ncbi.nlm.nih.gov/pubmed/24324543 !??,http://www.ncbi.nlm.nih.gov/pubmed/23769235 #4<,http://www.ncbi.nlm.nih.gov/pubmed/23678180 %19,http://www.ncbi.nlm.nih.gov/pubmed/23570768 *<6,http://www.ncbi.nlm.nih.gov/pubmed/23468921 /43,http://www.ncbi.nlm.nih.gov/pubmed/23324818 #80,http://www.ncbi.nlm.nih.gov/pubmed/23241293 &;-,http://www.ncbi.nlm.nih.gov/pubmed/23121190 "6*,http://www.ncbi.nlm.nih.gov/pubmed/23113663 ,7',http://www.ncbi.nlm.nih.gov/pubmed/23082173 %;$,http://www.ncbi.nlm.nih.gov/pubmed/22358421 #2!,http://www.ncbi.nlm.nih.gov/pubmed/21757105 ,6,http://www.ncbi.nlm.nih.gov/pubmed/21396216 "3,http://www.ncbi.nlm.nih.gov/pubmed/21115454 %0,http://www.ncbi.nlm.nih.gov/pubmed/20576417  ?,http://www.ncbi.nlm.nih.gov/pubmed/20835509 $0,http://www.ncbi.nlm.nih.gov/pubmed/20737129 !7,http://www.ncbi.nlm.nih.gov/pubmed/20655261 ,2 ,http://www.ncbi.nlm.nih.gov/pubmed/20186278 qk http://www.ncbi.nlm.nih.gov/pubmed/19919775?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1 wohttp://www.ncbi.nlm.nih.gov/pubmed/19828532?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2 tghttp://www.ncbi.nlm.nih.gov/pubmed/19586789?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=5 pYhttp://www.ncbi.nlm.nih.gov/pubmed/18829671?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmopqrstuwxyz{|}~Root Entry F1;Data 1TableWordDocument GSummaryInformation(nDocumentSummaryInformation8vtMsoDataStore$; J,;XSUGA2QKXPQ==2$; J,;Item  PropertiesUMacros J,; J,;VBA J,; J,;  !#$%&'()*+,-./0123456789:;<=>?@ABCDEGHIJKN 0* pHdProjectQ(@= l P J< rstdole>stdoleP h%^*\G{00020430-C 0046}#2.0#0#C:\WINDOWS\system32\e2.tlb#OLE Automation`ENormalENCrmaQF  *\C m! OfficgOficg!G{2DF8D04C-5BFA-101B-BHDE5gAAe42gArchivos de programa\ comunes\Microsoft Shared\OFFICEdir ThisDocument _VBA_PROJECT"PROJECT FB12\MSO.DLL#S 1 Obt Library@(B}IhThisDocumentG TiisDKcuLenq* 2 HB1BE,!"B+BBIxME (S"SS"<(1Normal.ThisDocument8(%HxAttribute VB_Name = "ThisDocument" Bas1Normal.VGlobal!SpaclFalse CreatablPre declaIdTru BExposeTemplateDeriv$Custom izC1a  *\G{000204EF-0000-0000-C000-000000000046}#4.0#9#C:\ARCHIV~1\ARCHIV~1\MICROS~1\VBA\VBA6\VBE6.DLL#Visual Basic For Applications*\G{00020905-0000-0000-C000-000000000046}#8.4#0#C:\Archivos de programa\Microsoft Office\Office12\MSWORD.OLB#Microsoft Word 12.0 Object Library*\G{00020430-0000-0000-C000-000000000046}#2.0#0#C:\WINDOWS\system32\stdole2.tlb#OLE Automation*\CNormal*\CNormalP>*\G{2DF8D04C-5BFA-101B-BDE5-00AA0044DE52}#2.4#0#C:\Archivos de programa\Archivos comunes\Microsoft Shared\OFFICE12\MSO.DLL#Microsoft Office 12.0 Object Library P IThisDocument0350c0effbThisDocument * Bt+ `  %WordkVBAWin16~Win32MacVBA6# Proyecto1istdole`Project- ThisDocument< _EvaluateNormalOfficeuT ID="{A1975807-7D17-40BA-9300-D554DE381F16}" Document=ThisDocument/&H00000000 Name="Project" HelpContextID="0" VersionCompatible32="393222000" CMG="BBB917DED6E2D6E2D6E2D6E2" DPB="7674DA9B2EEDE8EEE8EEE8" GC="31339DDE9EDE9E21" [Host Extender Info] &H00000001={3832D640-CF90-11CF-8E43-00A0C911005A};VBE;&H00000000 ThisDocumentThisDocument  F+Documento de Microsoft Office Word 97-2003 MSWordDocWord.Document.89qPROJECTwmL)CompObjM}